Go to the Table of Contents

Search tables for keyword
Please note: A selected table may take a few minutes to load.

230724
Table 7.1A – Types and Locations of Mental Health Treatment and Other Services in Past Year: Among People Aged 12 to 17, by Age Group, Numbers in Thousands, 2021 and 2022
Type/Location of Treatment or Other Services Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
MENTAL HEALTH TREATMENT OR OTHER SERVICES -- 8,200 -- 2,697 -- 2,991 -- 2,513
MENTAL HEALTH TREATMENT -- 7,669 -- 2,508 -- 2,769 -- 2,392
Inpatient -- 783 -- 281 -- 278 -- 224
Hospital -- 551 -- 179 -- 214 -- 158
Residential Mental Health Treatment Center -- 394 -- 138 -- 132 -- 124
Residential Drug or Alcohol Rehab or Treatment Center -- 69 -- 24 -- 19 -- 26
Some Other Place as an Inpatient -- 157 -- 65 -- 46 -- 47
Outpatient -- 5,907 -- 1,941 -- 2,128 -- 1,838
Mental Health Treatment Center -- 954 -- 231 -- 357 -- 365
Drug or Alcohol Rehab or Treatment Center -- 61 -- 16 -- 14 -- 31
Office of a Therapist, Psychologist, Psychiatrist, or Mental
   Health Professional
-- 3,340 -- 885 -- 1,212 -- 1,243
General Medical Clinic or Doctor’s Office -- 2,430 -- 834 -- 811 -- 784
Hospital -- 504 -- 136 -- 207 -- 160
School’s Health or Counseling Center -- 3,135 -- 1,140 -- 1,108 -- 887
Some Other Place as an Outpatient -- 194 -- 84 -- 69 -- 41
Outpatient, Other Than General Medical Clinic or Doctor’s
   Office
-- 5,145 -- 1,653 -- 1,858 -- 1,633
Prescription Medication -- 3,287 -- 1,009 -- 1,131 -- 1,147
Telehealth Treatment1 -- 3,561 -- 913 -- 1,264 -- 1,384
Prison, Jail, or Juvenile Detention Center -- 304 -- 80 -- 145 -- 78
OTHER SERVICES                
Support Services                
Support Group -- 1,855 -- 586 -- 755 -- 514
Peer Support Specialist or Recovery Coach -- 785 -- 258 -- 315 -- 212
Emergency Room/Department -- 691 -- 235 -- 258 -- 197
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment or other services; thus, these response categories are not mutually exclusive.
1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.1B – Types and Locations of Mental Health Treatment and Other Services in Past Year: Among People Aged 12 to 17, by Age Group, Percentages, 2021 and 2022
Type/Location of Treatment or Other Services Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
MENTAL HEALTH TREATMENT OR OTHER SERVICES -- 31.9 -- 32.0 -- 33.0 -- 30.6
MENTAL HEALTH TREATMENT -- 29.8 -- 29.7 -- 30.6 -- 29.1
Inpatient -- 3.0 -- 3.3 -- 3.1 -- 2.7
Hospital -- 2.1 -- 2.1 -- 2.4 -- 1.9
Residential Mental Health Treatment Center -- 1.5 -- 1.6 -- 1.5 -- 1.5
Residential Drug or Alcohol Rehab or Treatment Center -- 0.3 -- 0.3 -- 0.2 -- 0.3
Some Other Place as an Inpatient -- 0.6 -- 0.8 -- 0.5 -- 0.6
Outpatient -- 23.0 -- 23.0 -- 23.5 -- 22.3
Mental Health Treatment Center -- 3.7 -- 2.7 -- 3.9 -- 4.4
Drug or Alcohol Rehab or Treatment Center -- 0.2 -- 0.2 -- 0.2 -- 0.4
Office of a Therapist, Psychologist, Psychiatrist, or Mental
   Health Professional
-- 13.0 -- 10.5 -- 13.4 -- 15.1
General Medical Clinic or Doctor’s Office -- 9.4 -- 9.9 -- 8.9 -- 9.5
Hospital -- 2.0 -- 1.6 -- 2.3 -- 1.9
School’s Health or Counseling Center -- 12.2 -- 13.5 -- 12.2 -- 10.8
Some Other Place as an Outpatient -- 0.8 -- 1.0 -- 0.8 -- 0.5
Outpatient, Other Than General Medical Clinic or Doctor’s
   Office
-- 20.0 -- 19.6 -- 20.5 -- 19.9
Prescription Medication -- 12.8 -- 12.0 -- 12.5 -- 14.0
Telehealth Treatment1 -- 13.8 -- 10.8 -- 14.0 -- 16.8
Prison, Jail, or Juvenile Detention Center -- 1.2 -- 0.9 -- 1.6 -- 1.0
OTHER SERVICES                
Support Services                
Support Group -- 7.2 -- 6.9 -- 8.3 -- 6.3
Peer Support Specialist or Recovery Coach -- 3.1 -- 3.1 -- 3.5 -- 2.6
Emergency Room/Department -- 2.7 -- 2.8 -- 2.9 -- 2.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment or other services; thus, these response categories are not mutually exclusive.
1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.2A – Types and Locations of Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Mental
Health
Treatment
(2021)
Mental
Health
Treatment
(2022)
Inpatient
(2021)
Inpatient
(2022)
Outpatient
(2021)
Outpatient
(2022)
Prescription
Medication
(2021)
Prescription
Medication
(2022)
Telehealth
Treatment1
(2021)
Telehealth
Treatment1
(2022)
Prison, Jail,
or Juvenile
Detention
Center
(2021)
Prison, Jail,
or Juvenile
Detention
Center
(2022)
TOTAL -- 7,669 -- 783 -- 5,907 -- 3,287 -- 3,561 -- 304
AGE GROUP                        
12-13 -- 2,508 -- 281 -- 1,941 -- 1,009 -- 913 -- 80
14-15 -- 2,769 -- 278 -- 2,128 -- 1,131 -- 1,264 -- 145
16-17 -- 2,392 -- 224 -- 1,838 -- 1,147 -- 1,384 -- 78
GENDER                        
Male -- 3,263 -- 314 -- 2,250 -- 1,468 -- 1,282 -- 133
Female -- 4,406 -- 469 -- 3,658 -- 1,819 -- 2,279 -- 171
HISPANIC ORIGIN AND RACE                        
Not Hispanic or Latino -- 5,829 -- 591 -- 4,427 -- 2,602 -- 2,770 -- 226
AIAN -- * -- 13 -- 51 -- 30 -- * -- 1
Asian -- 326 -- 31 -- 268 -- 69 -- 114 -- 17
Black or African American -- 859 -- 168 -- 614 -- 304 -- 295 -- 34
NHOPI -- * -- * -- * -- * -- * -- *
White -- 4,292 -- 350 -- 3,268 -- 2,086 -- 2,186 -- 156
Two or More Races -- 266 -- 26 -- 216 -- 112 -- 135 -- 18
Hispanic or Latino -- 1,840 -- 192 -- 1,481 -- 685 -- 791 -- 77
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive.
1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.2B – Types and Locations of Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Mental
Health
Treatment
(2021)
Mental
Health
Treatment
(2022)
Inpatient
(2021)
Inpatient
(2022)
Outpatient
(2021)
Outpatient
(2022)
Prescription
Medication
(2021)
Prescription
Medication
(2022)
Telehealth
Treatment1
(2021)
Telehealth
Treatment1
(2022)
Prison, Jail,
or Juvenile
Detention
Center
(2021)
Prison, Jail,
or Juvenile
Detention
Center
(2022)
TOTAL -- 29.8 -- 3.0 -- 23.0 -- 12.8 -- 13.8 -- 1.2
AGE GROUP                        
12-13 -- 29.7 -- 3.3 -- 23.0 -- 12.0 -- 10.8 -- 0.9
14-15 -- 30.6 -- 3.1 -- 23.5 -- 12.5 -- 14.0 -- 1.6
16-17 -- 29.1 -- 2.7 -- 22.3 -- 14.0 -- 16.8 -- 1.0
GENDER                        
Male -- 24.8 -- 2.4 -- 17.1 -- 11.2 -- 9.7 -- 1.0
Female -- 35.1 -- 3.7 -- 29.1 -- 14.5 -- 18.1 -- 1.4
HISPANIC ORIGIN AND RACE                        
Not Hispanic or Latino -- 30.6 -- 3.1 -- 23.2 -- 13.6 -- 14.5 -- 1.2
AIAN -- * -- 5.8 -- 23.0 -- 13.5 -- * -- 0.6
Asian -- 20.3 -- 1.9 -- 16.7 -- 4.3 -- 7.1 -- 1.0
Black or African American -- 24.5 -- 4.8 -- 17.5 -- 8.7 -- 8.4 -- 1.0
NHOPI -- * -- * -- * -- * -- * -- *
White -- 33.4 -- 2.7 -- 25.4 -- 16.2 -- 17.0 -- 1.2
Two or More Races -- 31.9 -- 3.2 -- 25.9 -- 13.5 -- 16.2 -- 2.2
Hispanic or Latino -- 27.7 -- 2.9 -- 22.3 -- 10.3 -- 11.9 -- 1.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive.
1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.3A – Types and Locations of Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/
Health Characteristic
Mental
Health
Treatment
(2021)
Mental
Health
Treatment
(2022)
Inpatient
(2021)
Inpatient
(2022)
Outpatient
(2021)
Outpatient
(2022)
Prescription
Medication
(2021)
Prescription
Medication
(2022)
Telehealth
Treatment1
(2021)
Telehealth
Treatment1
(2022)
Prison, Jail,
or Juvenile
Detention
Center
(2021)
Prison, Jail,
or Juvenile
Detention
Center
(2022)
TOTAL -- 7,669 -- 783 -- 5,907 -- 3,287 -- 3,561 -- 304
GEOGRAPHIC REGION                        
Northeast -- 1,257 -- 130 -- 1,020 -- 447 -- 671 -- 46
Midwest -- 1,706 -- 151 -- 1,305 -- 771 -- 744 -- 70
South -- 2,914 -- 348 -- 2,173 -- 1,379 -- 1,224 -- 96
West -- 1,792 -- 153 -- 1,409 -- 690 -- 922 -- 91
COUNTY TYPE                        
Large Metro -- 4,355 -- 422 -- 3,395 -- 1,760 -- 2,076 -- 159
Small Metro -- 2,475 -- 269 -- 1,880 -- 1,123 -- 1,150 -- 104
Nonmetro -- 839 -- 92 -- 633 -- 405 -- 336 -- 41
Urbanized -- 385 -- 41 -- 296 -- 173 -- 171 -- 27
Less Urbanized -- 402 -- 27 -- 295 -- 206 -- 144 -- 12
Completely Rural -- * -- * -- * -- 25 -- 21 -- 2
POVERTY LEVEL                        
Less Than 100% -- 1,321 -- 218 -- 980 -- 516 -- 528 -- 82
100-199% -- 1,734 -- 196 -- 1,320 -- 735 -- 705 -- 56
200% or More -- 4,614 -- 369 -- 3,607 -- 2,036 -- 2,328 -- 166
HEALTH INSURANCE2                        
Private -- 4,439 -- 338 -- 3,487 -- 1,915 -- 2,219 -- 144
Medicaid/CHIP -- 3,199 -- 430 -- 2,422 -- 1,414 -- 1,359 -- 166
Other3 -- 399 -- 51 -- 305 -- 178 -- 161 -- 22
No Coverage -- 191 -- 25 -- 132 -- 35 -- 57 -- *
OVERALL HEALTH4                        
Excellent -- 1,643 -- 127 -- 1,264 -- 580 -- 581 -- 41
Very Good -- 3,070 -- 257 -- 2,355 -- 1,236 -- 1,433 -- 118
Good -- 2,320 -- 266 -- 1,784 -- 1,139 -- 1,202 -- 119
Fair/Poor -- 634 -- 133 -- 504 -- 331 -- 345 -- 26
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive.
1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
4 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.3B – Types and Locations of Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/
Health Characteristic
Mental
Health
Treatment
(2021)
Mental
Health
Treatment
(2022)
Inpatient
(2021)
Inpatient
(2022)
Outpatient
(2021)
Outpatient
(2022)
Prescription
Medication
(2021)
Prescription
Medication
(2022)
Telehealth
Treatment1
(2021)
Telehealth
Treatment1
(2022)
Prison, Jail,
or Juvenile
Detention
Center
(2021)
Prison, Jail,
or Juvenile
Detention
Center
(2022)
TOTAL -- 29.8 -- 3.0 -- 23.0 -- 12.8 -- 13.8 -- 1.2
GEOGRAPHIC REGION                        
Northeast -- 30.9 -- 3.2 -- 25.1 -- 11.0 -- 16.5 -- 1.1
Midwest -- 31.6 -- 2.8 -- 24.2 -- 14.3 -- 13.8 -- 1.3
South -- 28.8 -- 3.4 -- 21.5 -- 13.6 -- 12.1 -- 1.0
West -- 29.2 -- 2.5 -- 22.9 -- 11.2 -- 15.0 -- 1.5
COUNTY TYPE                        
Large Metro -- 29.4 -- 2.8 -- 22.9 -- 11.9 -- 14.0 -- 1.1
Small Metro -- 31.1 -- 3.4 -- 23.6 -- 14.1 -- 14.4 -- 1.3
Nonmetro -- 28.6 -- 3.1 -- 21.6 -- 13.8 -- 11.5 -- 1.4
Urbanized -- 31.1 -- 3.3 -- 23.9 -- 14.0 -- 13.8 -- 2.1
Less Urbanized -- 28.4 -- 1.9 -- 20.9 -- 14.6 -- 10.2 -- 0.8
Completely Rural -- * -- * -- * -- 9.1 -- 7.4 -- 0.8
POVERTY LEVEL                        
Less Than 100% -- 25.0 -- 4.1 -- 18.6 -- 9.8 -- 10.0 -- 1.5
100-199% -- 29.9 -- 3.4 -- 22.8 -- 12.7 -- 12.2 -- 1.0
200% or More -- 31.5 -- 2.5 -- 24.6 -- 13.9 -- 15.9 -- 1.1
HEALTH INSURANCE2                        
Private -- 31.5 -- 2.4 -- 24.8 -- 13.6 -- 15.8 -- 1.0
Medicaid/CHIP -- 30.0 -- 4.0 -- 22.7 -- 13.2 -- 12.7 -- 1.6
Other3 -- 26.5 -- 3.4 -- 20.2 -- 11.8 -- 10.7 -- 1.5
No Coverage -- 18.9 -- 2.5 -- 13.1 -- 3.5 -- 5.6 -- *
OVERALL HEALTH4                        
Excellent -- 20.4 -- 1.6 -- 15.7 -- 7.2 -- 7.2 -- 0.5
Very Good -- 30.3 -- 2.5 -- 23.2 -- 12.2 -- 14.1 -- 1.2
Good -- 37.0 -- 4.2 -- 28.5 -- 18.2 -- 19.2 -- 1.9
Fair/Poor -- 50.5 -- 10.6 -- 40.0 -- 26.3 -- 27.5 -- 2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive.
1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
4 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.4A – Received Mental Health Treatment as an Inpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 783 -- 369 -- 335 -- 376
AGE GROUP                
12-13 -- 281 -- 103 -- 88 -- 160
14-15 -- 278 -- 162 -- 152 -- 101
16-17 -- 224 -- 105 -- 94 -- 114
GENDER                
Male -- 314 -- 96 -- 90 -- 207
Female -- 469 -- 273 -- 244 -- 168
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 591 -- 276 -- 250 -- 290
AIAN -- 13 -- * -- * -- 2
Asian -- 31 -- * -- * -- 3
Black or African American -- 168 -- 41 -- 39 -- 119
NHOPI -- * -- * -- * -- *
White -- 350 -- 189 -- 171 -- 148
Two or More Races -- 26 -- 9 -- 8 -- 17
Hispanic or Latino -- 192 -- 93 -- 85 -- 86
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.4B – Received Mental Health Treatment as an Inpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 3.0 -- 7.7 -- 9.3 -- 1.9
AGE GROUP                
12-13 -- 3.3 -- 10.0 -- 12.3 -- 2.3
14-15 -- 3.1 -- 8.6 -- 10.7 -- 1.5
16-17 -- 2.7 -- 5.5 -- 6.5 -- 1.9
GENDER                
Male -- 2.4 -- 6.6 -- 9.1 -- 1.8
Female -- 3.7 -- 8.1 -- 9.4 -- 1.9
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 3.1 -- 7.7 -- 9.4 -- 2.0
AIAN -- 5.8 -- * -- * -- 1.0
Asian -- 1.9 -- * -- * -- 0.2
Black or African American -- 4.8 -- 7.3 -- 9.7 -- 4.2
NHOPI -- * -- * -- * -- *
White -- 2.7 -- 7.2 -- 8.7 -- 1.5
Two or More Races -- 3.2 -- 5.6 -- 7.8 -- 2.6
Hispanic or Latino -- 2.9 -- 7.5 -- 9.2 -- 1.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.5A – Received Mental Health Treatment as an Inpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 783 -- 369 -- 335 -- 376
GEOGRAPHIC REGION                
Northeast -- 130 -- 65 -- 50 -- 60
Midwest -- 151 -- 68 -- 67 -- 78
South -- 348 -- 145 -- 134 -- 187
West -- 153 -- 90 -- 83 -- 50
COUNTY TYPE                
Large Metro -- 422 -- 206 -- 192 -- 199
Small Metro -- 269 -- 117 -- 100 -- 135
Nonmetro -- 92 -- 46 -- * -- 41
POVERTY LEVEL                
Less Than 100% -- 218 -- 85 -- 77 -- 131
100-199% -- 196 -- 98 -- 86 -- 84
200% or More -- 369 -- 187 -- 171 -- 161
HEALTH INSURANCE4                
Private -- 338 -- 175 -- 163 -- 144
Medicaid/CHIP -- 430 -- 205 -- 187 -- 211
Other5 -- 51 -- 20 -- * -- 27
No Coverage -- 25 -- * -- * -- 15
OVERALL HEALTH6                
Excellent -- 127 -- 39 -- 27 -- 85
Very Good -- 257 -- 81 -- 76 -- 159
Good -- 266 -- 144 -- 138 -- 106
Fair/Poor -- 133 -- 106 -- 93 -- 25
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.5B – Received Mental Health Treatment as an Inpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 3.0 -- 7.7 -- 9.3 -- 1.9
GEOGRAPHIC REGION                
Northeast -- 3.2 -- 9.2 -- 9.8 -- 1.9
Midwest -- 2.8 -- 7.2 -- 9.2 -- 1.8
South -- 3.4 -- 7.7 -- 9.4 -- 2.4
West -- 2.5 -- 7.1 -- 9.0 -- 1.1
COUNTY TYPE                
Large Metro -- 2.8 -- 7.4 -- 9.2 -- 1.7
Small Metro -- 3.4 -- 7.7 -- 8.9 -- 2.2
Nonmetro -- 3.1 -- 8.7 -- * -- 1.8
POVERTY LEVEL                
Less Than 100% -- 4.1 -- 10.2 -- 12.6 -- 3.1
100-199% -- 3.4 -- 8.5 -- 9.5 -- 1.9
200% or More -- 2.5 -- 6.6 -- 8.2 -- 1.4
HEALTH INSURANCE4                
Private -- 2.4 -- 6.5 -- 8.3 -- 1.3
Medicaid/CHIP -- 4.0 -- 10.3 -- 12.0 -- 2.6
Other5 -- 3.4 -- 6.8 -- * -- 2.3
No Coverage -- 2.5 -- * -- * -- 1.9
OVERALL HEALTH6                
Excellent -- 1.6 -- 4.9 -- 4.8 -- 1.2
Very Good -- 2.5 -- 4.5 -- 5.8 -- 2.0
Good -- 4.2 -- 8.3 -- 10.5 -- 2.5
Fair/Poor -- 10.6 -- 21.1 -- 22.8 -- 3.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.6A – Received Mental Health Treatment as an Outpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 5,907 -- 2,318 -- 1,927 -- 3,341
AGE GROUP                
12-13 -- 1,941 -- 520 -- 418 -- 1,300
14-15 -- 2,128 -- 932 -- 762 -- 1,121
16-17 -- 1,838 -- 865 -- 747 -- 920
GENDER                
Male -- 2,250 -- 548 -- 453 -- 1,633
Female -- 3,658 -- 1,770 -- 1,474 -- 1,709
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 4,427 -- 1,742 -- 1,448 -- 2,503
AIAN -- 51 -- * -- * -- *
Asian -- 268 -- * -- * -- 144
Black or African American -- 614 -- 180 -- 158 -- 398
NHOPI -- * -- * -- * -- *
White -- 3,268 -- 1,379 -- 1,143 -- 1,773
Two or More Races -- 216 -- * -- * -- 145
Hispanic or Latino -- 1,481 -- 576 -- 479 -- 839
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.6B – Received Mental Health Treatment as an Outpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 23.0 -- 48.1 -- 53.6 -- 16.8
AGE GROUP                
12-13 -- 23.0 -- 50.5 -- 58.2 -- 18.9
14-15 -- 23.5 -- 49.5 -- 53.7 -- 16.2
16-17 -- 22.3 -- 45.3 -- 51.2 -- 15.1
GENDER                
Male -- 17.1 -- 37.7 -- 45.4 -- 14.6
Female -- 29.1 -- 52.5 -- 56.7 -- 19.7
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 23.2 -- 48.5 -- 54.2 -- 16.9
AIAN -- 23.0 -- * -- * -- *
Asian -- 16.7 -- * -- * -- 10.9
Black or African American -- 17.5 -- 31.9 -- 39.2 -- 14.1
NHOPI -- * -- * -- * -- *
White -- 25.4 -- 52.9 -- 58.0 -- 18.1
Two or More Races -- 25.9 -- * -- * -- 22.4
Hispanic or Latino -- 22.3 -- 46.7 -- 51.8 -- 16.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.7A – Received Mental Health Treatment as an Outpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 5,907 -- 2,318 -- 1,927 -- 3,341
GEOGRAPHIC REGION                
Northeast -- 1,020 -- 365 -- 284 -- 617
Midwest -- 1,305 -- 463 -- 387 -- 790
South -- 2,173 -- 867 -- 720 -- 1,202
West -- 1,409 -- 623 -- 536 -- 732
COUNTY TYPE                
Large Metro -- 3,395 -- 1,302 -- 1,109 -- 1,950
Small Metro -- 1,880 -- 759 -- 619 -- 1,039
Nonmetro -- 633 -- 257 -- 199 -- 352
POVERTY LEVEL                
Less Than 100% -- 980 -- 362 -- 295 -- 575
100-199% -- 1,320 -- 511 -- 452 -- 726
200% or More -- 3,607 -- 1,444 -- 1,180 -- 2,040
HEALTH INSURANCE4                
Private -- 3,487 -- 1,367 -- 1,120 -- 1,986
Medicaid/CHIP -- 2,422 -- 927 -- 789 -- 1,385
Other5 -- 305 -- * -- * -- 173
No Coverage -- 132 -- * -- * -- 60
OVERALL HEALTH6                
Excellent -- 1,264 -- 298 -- 222 -- 922
Very Good -- 2,355 -- 828 -- 685 -- 1,429
Good -- 1,784 -- 859 -- 732 -- 827
Fair/Poor -- 504 -- 333 -- 288 -- 163
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.7B – Received Mental Health Treatment as an Outpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 23.0 -- 48.1 -- 53.6 -- 16.8
GEOGRAPHIC REGION                
Northeast -- 25.1 -- 51.2 -- 55.6 -- 19.4
Midwest -- 24.2 -- 48.5 -- 52.7 -- 18.6
South -- 21.5 -- 45.9 -- 50.4 -- 15.3
West -- 22.9 -- 49.2 -- 58.0 -- 15.9
COUNTY TYPE                
Large Metro -- 22.9 -- 47.0 -- 53.0 -- 17.0
Small Metro -- 23.6 -- 49.8 -- 54.8 -- 17.0
Nonmetro -- 21.6 -- 48.6 -- 53.0 -- 15.4
POVERTY LEVEL                
Less Than 100% -- 18.6 -- 43.5 -- 47.9 -- 13.7
100-199% -- 22.8 -- 44.5 -- 50.1 -- 16.5
200% or More -- 24.6 -- 50.8 -- 56.8 -- 18.1
HEALTH INSURANCE4                
Private -- 24.8 -- 50.6 -- 57.3 -- 18.2
Medicaid/CHIP -- 22.7 -- 46.6 -- 50.8 -- 16.8
Other5 -- 20.2 -- * -- * -- 15.1
No Coverage -- 13.1 -- * -- * -- 7.7
OVERALL HEALTH6                
Excellent -- 15.7 -- 37.5 -- 39.4 -- 13.1
Very Good -- 23.2 -- 46.2 -- 52.3 -- 17.9
Good -- 28.5 -- 49.5 -- 55.8 -- 19.9
Fair/Poor -- 40.0 -- 66.4 -- 70.3 -- 23.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.8A – Received Mental Health Treatment through Prescription Medication in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 3,287 -- 1,358 -- 1,159 -- 1,790
AGE GROUP                
12-13 -- 1,009 -- 273 -- 229 -- 673
14-15 -- 1,131 -- 514 -- 427 -- 575
16-17 -- 1,147 -- 571 -- 504 -- 541
GENDER                
Male -- 1,468 -- 368 -- 292 -- 1,046
Female -- 1,819 -- 989 -- 867 -- 743
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 2,602 -- 1,056 -- 876 -- 1,431
AIAN -- 30 -- * -- * -- *
Asian -- 69 -- * -- * -- 30
Black or African American -- 304 -- 80 -- 53 -- 205
NHOPI -- * -- * -- * -- *
White -- 2,086 -- 890 -- 742 -- 1,104
Two or More Races -- 112 -- * -- * -- 72
Hispanic or Latino -- 685 -- 302 -- 284 -- 359
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.8B – Received Mental Health Treatment through Prescription Medication in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 12.8 -- 28.1 -- 32.2 -- 9.0
AGE GROUP                
12-13 -- 12.0 -- 26.4 -- 31.9 -- 9.8
14-15 -- 12.5 -- 27.3 -- 30.1 -- 8.3
16-17 -- 14.0 -- 29.9 -- 34.5 -- 8.9
GENDER                
Male -- 11.2 -- 25.4 -- 29.3 -- 9.3
Female -- 14.5 -- 29.3 -- 33.4 -- 8.6
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 13.6 -- 29.4 -- 32.8 -- 9.7
AIAN -- 13.5 -- * -- * -- *
Asian -- 4.3 -- * -- * -- 2.3
Black or African American -- 8.7 -- 14.1 -- 13.3 -- 7.3
NHOPI -- * -- * -- * -- *
White -- 16.2 -- 34.1 -- 37.7 -- 11.3
Two or More Races -- 13.5 -- * -- * -- 11.0
Hispanic or Latino -- 10.3 -- 24.5 -- 30.6 -- 7.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.9A – Received Mental Health Treatment through Prescription Medication in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 3,287 -- 1,358 -- 1,159 -- 1,790
GEOGRAPHIC REGION                
Northeast -- 447 -- 165 -- 129 -- 264
Midwest -- 771 -- 274 -- 244 -- 466
South -- 1,379 -- 546 -- 447 -- 756
West -- 690 -- 372 -- 340 -- 303
COUNTY TYPE                
Large Metro -- 1,760 -- 740 -- 636 -- 942
Small Metro -- 1,123 -- 476 -- 412 -- 603
Nonmetro -- 405 -- 142 -- 111 -- 244
POVERTY LEVEL                
Less Than 100% -- 516 -- 211 -- 176 -- 271
100-199% -- 735 -- 311 -- 271 -- 387
200% or More -- 2,036 -- 836 -- 713 -- 1,131
HEALTH INSURANCE4                
Private -- 1,915 -- 819 -- 687 -- 1,032
Medicaid/CHIP -- 1,414 -- 543 -- 474 -- 800
Other5 -- 178 -- * -- * -- 94
No Coverage -- 35 -- * -- * -- 22
OVERALL HEALTH6                
Excellent -- 580 -- 162 -- 129 -- 402
Very Good -- 1,236 -- 408 -- 345 -- 772
Good -- 1,139 -- 565 -- 493 -- 510
Fair/Poor -- 331 -- 222 -- 192 -- 104
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.9B – Received Mental Health Treatment through Prescription Medication in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 12.8 -- 28.1 -- 32.2 -- 9.0
GEOGRAPHIC REGION                
Northeast -- 11.0 -- 23.2 -- 25.2 -- 8.3
Midwest -- 14.3 -- 28.7 -- 33.2 -- 11.0
South -- 13.6 -- 28.9 -- 31.3 -- 9.6
West -- 11.2 -- 29.4 -- 36.8 -- 6.6
COUNTY TYPE                
Large Metro -- 11.9 -- 26.7 -- 30.4 -- 8.2
Small Metro -- 14.1 -- 31.3 -- 36.5 -- 9.9
Nonmetro -- 13.8 -- 26.8 -- 29.5 -- 10.7
POVERTY LEVEL                
Less Than 100% -- 9.8 -- 25.3 -- 28.5 -- 6.5
100-199% -- 12.7 -- 27.0 -- 30.1 -- 8.8
200% or More -- 13.9 -- 29.4 -- 34.3 -- 10.0
HEALTH INSURANCE4                
Private -- 13.6 -- 30.3 -- 35.1 -- 9.5
Medicaid/CHIP -- 13.2 -- 27.3 -- 30.6 -- 9.7
Other5 -- 11.8 -- * -- * -- 8.2
No Coverage -- 3.5 -- * -- * -- 2.8
OVERALL HEALTH6                
Excellent -- 7.2 -- 20.4 -- 22.8 -- 5.7
Very Good -- 12.2 -- 22.8 -- 26.4 -- 9.7
Good -- 18.2 -- 32.5 -- 37.6 -- 12.3
Fair/Poor -- 26.3 -- 44.3 -- 46.9 -- 15.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.10A – Received Mental Health Treatment through Telehealth in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 3,561 -- 1,661 -- 1,405 -- 1,761
AGE GROUP                
12-13 -- 913 -- 324 -- 269 -- 527
14-15 -- 1,264 -- 679 -- 572 -- 545
16-17 -- 1,384 -- 658 -- 564 -- 689
GENDER                
Male -- 1,282 -- 440 -- 358 -- 805
Female -- 2,279 -- 1,221 -- 1,047 -- 956
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 2,770 -- 1,273 -- 1,064 -- 1,380
AIAN -- * -- * -- * -- *
Asian -- 114 -- * -- * -- 56
Black or African American -- 295 -- 130 -- 114 -- 158
NHOPI -- * -- * -- * -- *
White -- 2,186 -- 1,040 -- 859 -- 1,052
Two or More Races -- 135 -- 38 -- * -- 87
Hispanic or Latino -- 791 -- 387 -- 341 -- 381
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.10B – Received Mental Health Treatment through Telehealth in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 13.8 -- 34.4 -- 39.1 -- 8.9
AGE GROUP                
12-13 -- 10.8 -- 31.4 -- 37.5 -- 7.7
14-15 -- 14.0 -- 36.1 -- 40.3 -- 7.9
16-17 -- 16.8 -- 34.4 -- 38.6 -- 11.3
GENDER                
Male -- 9.7 -- 30.3 -- 35.9 -- 7.2
Female -- 18.1 -- 36.2 -- 40.3 -- 11.0
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 14.5 -- 35.5 -- 39.8 -- 9.3
AIAN -- * -- * -- * -- *
Asian -- 7.1 -- * -- * -- 4.3
Black or African American -- 8.4 -- 23.0 -- 28.4 -- 5.6
NHOPI -- * -- * -- * -- *
White -- 17.0 -- 39.9 -- 43.6 -- 10.8
Two or More Races -- 16.2 -- 24.6 -- * -- 13.4
Hispanic or Latino -- 11.9 -- 31.4 -- 36.9 -- 7.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.11A – Received Mental Health Treatment through Telehealth in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 3,561 -- 1,661 -- 1,405 -- 1,761
GEOGRAPHIC REGION                
Northeast -- 671 -- 295 -- 230 -- 349
Midwest -- 744 -- 307 -- 268 -- 410
South -- 1,224 -- 572 -- 482 -- 611
West -- 922 -- 487 -- 425 -- 391
COUNTY TYPE                
Large Metro -- 2,076 -- 963 -- 842 -- 1,047
Small Metro -- 1,150 -- 546 -- 444 -- 543
Nonmetro -- 336 -- 151 -- 120 -- 171
POVERTY LEVEL                
Less Than 100% -- 528 -- 247 -- 214 -- 261
100-199% -- 705 -- 309 -- 278 -- 356
200% or More -- 2,328 -- 1,104 -- 913 -- 1,143
HEALTH INSURANCE4                
Private -- 2,219 -- 1,041 -- 856 -- 1,102
Medicaid/CHIP -- 1,359 -- 618 -- 545 -- 682
Other5 -- 161 -- 77 -- * -- 77
No Coverage -- 57 -- * -- * -- 28
OVERALL HEALTH6                
Excellent -- 581 -- 177 -- 135 -- 388
Very Good -- 1,433 -- 607 -- 513 -- 769
Good -- 1,202 -- 642 -- 560 -- 495
Fair/Poor -- 345 -- 234 -- 197 -- 109
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.11B – Received Mental Health Treatment through Telehealth in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Aged 12-171
(2021)
Aged 12-171
(2022)
Had MDE2
(2021)
Had MDE2
(2022)
Had MDE
with Severe
Impairment2,3
(2021)
Had MDE
with Severe
Impairment2,3
(2022)
No MDE2
(2021)
No MDE2
(2022)
TOTAL -- 13.8 -- 34.4 -- 39.1 -- 8.9
GEOGRAPHIC REGION                
Northeast -- 16.5 -- 41.4 -- 45.0 -- 11.0
Midwest -- 13.8 -- 32.2 -- 36.5 -- 9.6
South -- 12.1 -- 30.3 -- 33.7 -- 7.8
West -- 15.0 -- 38.4 -- 46.1 -- 8.5
COUNTY TYPE                
Large Metro -- 14.0 -- 34.8 -- 40.2 -- 9.1
Small Metro -- 14.4 -- 35.8 -- 39.3 -- 8.9
Nonmetro -- 11.5 -- 28.6 -- 31.9 -- 7.5
POVERTY LEVEL                
Less Than 100% -- 10.0 -- 29.7 -- 34.8 -- 6.2
100-199% -- 12.2 -- 26.9 -- 30.8 -- 8.1
200% or More -- 15.9 -- 38.9 -- 43.9 -- 10.1
HEALTH INSURANCE4                
Private -- 15.8 -- 38.5 -- 43.8 -- 10.1
Medicaid/CHIP -- 12.7 -- 31.1 -- 35.2 -- 8.3
Other5 -- 10.7 -- 26.1 -- * -- 6.8
No Coverage -- 5.6 -- * -- * -- 3.6
OVERALL HEALTH6                
Excellent -- 7.2 -- 22.3 -- 23.9 -- 5.5
Very Good -- 14.1 -- 33.9 -- 39.2 -- 9.6
Good -- 19.2 -- 37.0 -- 42.7 -- 11.9
Fair/Poor -- 27.5 -- 46.7 -- 48.2 -- 15.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.12A – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 2,205 -- 381 -- 1,824 -- 15,520
AGE GROUP                
12-13 -- 446 -- 66 -- 380 -- 5,290
14-15 -- 840 -- 162 -- 678 -- 5,348
16-17 -- 920 -- 153 -- 766 -- 4,882
GENDER                
Male -- 683 -- 150 -- 533 -- 9,050
Female -- 1,522 -- 230 -- 1,291 -- 6,470
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 1,673 -- 252 -- 1,419 -- 11,377
AIAN -- 9 -- 1 -- 9 -- 136
Asian -- 194 -- 4 -- 190 -- 1,057
Black or African American -- 237 -- 20 -- 217 -- 2,384
NHOPI -- * -- * -- * -- *
White -- 1,163 -- 220 -- 942 -- 7,259
Two or More Races -- 69 -- 8 -- 61 -- 490
Hispanic or Latino -- 533 -- 128 -- 404 -- 4,143
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.12B – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 12.4 -- 2.1 -- 10.3 -- 87.6
AGE GROUP                
12-13 -- 7.8 -- 1.1 -- 6.6 -- 92.2
14-15 -- 13.6 -- 2.6 -- 10.9 -- 86.4
16-17 -- 15.9 -- 2.6 -- 13.2 -- 84.1
GENDER                
Male -- 7.0 -- 1.5 -- 5.5 -- 93.0
Female -- 19.0 -- 2.8 -- 16.1 -- 81.0
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 12.8 -- 1.9 -- 10.9 -- 87.2
AIAN -- 6.3 -- 0.4 -- 5.9 -- 93.7
Asian -- 15.5 -- 0.3 -- 15.2 -- 84.5
Black or African American -- 9.0 -- 0.7 -- 8.3 -- 91.0
NHOPI -- * -- * -- * -- *
White -- 13.8 -- 2.6 -- 11.2 -- 86.2
Two or More Races -- 12.3 -- 1.3 -- 11.0 -- 87.7
Hispanic or Latino -- 11.4 -- 2.7 -- 8.6 -- 88.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.13A – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought Should
Get Treatment
(2021)
Sought or
Thought Should
Get Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2021)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 2,205 -- 381 -- 1,824 -- 15,520
GEOGRAPHIC REGION                
Northeast -- 324 -- 39 -- 284 -- 2,455
Midwest -- 434 -- 69 -- 365 -- 3,198
South -- 849 -- 151 -- 698 -- 6,220
West -- 599 -- 122 -- 476 -- 3,647
COUNTY TYPE                
Large Metro -- 1,333 -- 235 -- 1,098 -- 8,944
Small Metro -- 627 -- 119 -- 507 -- 4,770
Nonmetro -- 246 -- 26 -- 218 -- 1,806
POVERTY LEVEL                
Less Than 100% -- 296 -- 64 -- 231 -- 3,578
100-199% -- 502 -- 85 -- 416 -- 3,452
200% or More -- 1,408 -- 231 -- 1,177 -- 8,490
HEALTH INSURANCE1                
Private -- 1,391 -- 223 -- 1,168 -- 8,099
Medicaid/CHIP -- 706 -- 141 -- 564 -- 6,615
Other2 -- 133 -- 36 -- 96 -- 960
No Coverage -- 77 -- 17 -- 60 -- 720
OVERALL HEALTH3                
Excellent -- 548 -- 97 -- 451 -- 5,815
Very Good -- 938 -- 159 -- 779 -- 5,997
Good -- 595 -- 99 -- 496 -- 3,237
Fair/Poor -- 124 -- 25 -- 99 -- 470
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
3 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.13B – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought Should
Get Treatment
(2021)
Sought or
Thought Should
Get Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2021)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 12.4 -- 2.1 -- 10.3 -- 87.6
GEOGRAPHIC REGION                
Northeast -- 11.7 -- 1.4 -- 10.2 -- 88.3
Midwest -- 11.9 -- 1.9 -- 10.0 -- 88.1
South -- 12.0 -- 2.1 -- 9.9 -- 88.0
West -- 14.1 -- 2.8 -- 11.2 -- 85.9
COUNTY TYPE                
Large Metro -- 13.0 -- 2.3 -- 10.7 -- 87.0
Small Metro -- 11.6 -- 2.2 -- 9.4 -- 88.4
Nonmetro -- 12.0 -- 1.3 -- 10.6 -- 88.0
POVERTY LEVEL                
Less Than 100% -- 7.6 -- 1.6 -- 5.9 -- 92.4
100-199% -- 12.7 -- 2.1 -- 10.5 -- 87.3
200% or More -- 14.2 -- 2.3 -- 11.9 -- 85.8
HEALTH INSURANCE1                
Private -- 14.7 -- 2.3 -- 12.3 -- 85.3
Medicaid/CHIP -- 9.6 -- 1.9 -- 7.7 -- 90.4
Other2 -- 12.1 -- 3.3 -- 8.8 -- 87.9
No Coverage -- 9.7 -- 2.1 -- 7.5 -- 90.3
OVERALL HEALTH3                
Excellent -- 8.6 -- 1.5 -- 7.1 -- 91.4
Very Good -- 13.5 -- 2.3 -- 11.2 -- 86.5
Good -- 15.5 -- 2.6 -- 12.9 -- 84.5
Fair/Poor -- 20.9 -- 4.1 -- 16.6 -- 79.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
3 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.14A – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Among People Aged 12 to 17 with Past Year Major Depressive Episode
Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 987 -- 181 -- 805 -- 1,057
AGE GROUP                
12-13 -- 170 -- 17 -- 153 -- 244
14-15 -- 397 -- 77 -- 320 -- 386
16-17 -- 420 -- 87 -- 332 -- 426
GENDER                
Male -- 270 -- * -- 196 -- 434
Female -- 717 -- 107 -- 609 -- 622
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 748 -- 115 -- 632 -- 723
AIAN -- * -- * -- * -- *
Asian -- * -- * -- * -- *
Black or African American -- 126 -- * -- 120 -- 189
NHOPI -- * -- * -- * -- *
White -- 499 -- 104 -- 395 -- 434
Two or More Races -- * -- * -- * -- *
Hispanic or Latino -- 239 -- * -- 174 -- 334
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.14B – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Among People Aged 12 to 17 with Past Year Major Depressive Episode
Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 48.3 -- 8.7 -- 39.4 -- 51.7
AGE GROUP                
12-13 -- 41.0 -- 3.8 -- 37.0 -- 59.0
14-15 -- 50.7 -- 9.7 -- 40.9 -- 49.3
16-17 -- 49.6 -- 10.3 -- 39.3 -- 50.4
GENDER                
Male -- 38.3 -- * -- 27.9 -- 61.7
Female -- 53.5 -- 7.9 -- 45.5 -- 46.5
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 50.8 -- 7.7 -- 43.0 -- 49.2
AIAN -- * -- * -- * -- *
Asian -- * -- * -- * -- *
Black or African American -- 40.0 -- * -- 38.2 -- 60.0
NHOPI -- * -- * -- * -- *
White -- 53.5 -- 11.1 -- 42.3 -- 46.5
Two or More Races -- * -- * -- * -- *
Hispanic or Latino -- 41.7 -- * -- 30.3 -- 58.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.15A – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought Should
Get Treatment
(2021)
Sought or
Thought Should
Get Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2021)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 987 -- 181 -- 805 -- 1,057
GEOGRAPHIC REGION                
Northeast -- 139 -- 20 -- 118 -- 157
Midwest -- 191 -- 41 -- 150 -- 184
South -- 372 -- 52 -- 320 -- 452
West -- 286 -- * -- 218 -- 263
COUNTY TYPE                
Large Metro -- 575 -- 108 -- 466 -- 633
Small Metro -- 292 -- 63 -- 229 -- 307
Nonmetro -- * -- * -- * -- *
POVERTY LEVEL                
Less Than 100% -- 152 -- * -- 115 -- 236
100-199% -- 234 -- 40 -- 194 -- 295
200% or More -- 602 -- 105 -- 497 -- 526
HEALTH INSURANCE1                
Private -- 560 -- 107 -- 452 -- 510
Medicaid/CHIP -- 393 -- 73 -- 319 -- 481
Other2 -- * -- * -- * -- *
No Coverage -- * -- * -- * -- *
OVERALL HEALTH3                
Excellent -- 204 -- 43 -- 161 -- 233
Very Good -- 410 -- 76 -- 333 -- 384
Good -- 314 -- 47 -- 267 -- 380
Fair/Poor -- * -- * -- * -- *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
3 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.15B – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought Should
Get Treatment
(2021)
Sought or
Thought Should
Get Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2021)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 48.3 -- 8.7 -- 39.4 -- 51.7
GEOGRAPHIC REGION                
Northeast -- 46.8 -- 6.8 -- 39.8 -- 53.2
Midwest -- 50.9 -- 10.4 -- 40.0 -- 49.1
South -- 45.1 -- 6.1 -- 38.9 -- 54.9
West -- 52.1 -- * -- 39.7 -- 47.9
COUNTY TYPE                
Large Metro -- 47.6 -- 8.7 -- 38.6 -- 52.4
Small Metro -- 48.8 -- 10.3 -- 38.3 -- 51.2
Nonmetro -- * -- * -- * -- *
POVERTY LEVEL                
Less Than 100% -- 39.2 -- * -- 29.7 -- 60.8
100-199% -- 44.2 -- 7.4 -- 36.6 -- 55.8
200% or More -- 53.4 -- 9.2 -- 44.1 -- 46.6
HEALTH INSURANCE1                
Private -- 52.4 -- 10.0 -- 42.3 -- 47.6
Medicaid/CHIP -- 45.0 -- 8.1 -- 36.6 -- 55.0
Other2 -- * -- * -- * -- *
No Coverage -- * -- * -- * -- *
OVERALL HEALTH3                
Excellent -- 46.7 -- 9.9 -- 36.8 -- 53.3
Very Good -- 51.6 -- 9.5 -- 42.0 -- 48.4
Good -- 45.2 -- 6.5 -- 38.5 -- 54.8
Fair/Poor -- * -- * -- * -- *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
3 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.16A – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Among People Aged 12 to 17 with Past Year Major Depressive Episode
with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year
Sought
or Thought
Should Get
Treatment
(2021)
Sought
or Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 760 -- 147 -- 612 -- 560
AGE GROUP                
12-13 -- 135 -- 13 -- 122 -- 100
14-15 -- 289 -- * -- 225 -- 236
16-17 -- 336 -- 70 -- 265 -- 225
GENDER                
Male -- 197 -- * -- 136 -- 210
Female -- 562 -- 85 -- 477 -- 350
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 573 -- 95 -- 478 -- 371
AIAN -- * -- * -- * -- *
Asian -- * -- * -- * -- *
Black or African American -- * -- * -- * -- *
NHOPI -- * -- * -- * -- *
White -- 392 -- 84 -- 308 -- 219
Two or More Races -- * -- * -- * -- *
Hispanic or Latino -- 186 -- * -- 135 -- 190
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.16B – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Among People Aged 12 to 17 with Past Year Major Depressive Episode
with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year
Sought
or Thought
Should Get
Treatment
(2021)
Sought
or Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 57.6 -- 10.8 -- 46.4 -- 42.4
AGE GROUP                
12-13 -- 57.4 -- 5.0 -- 51.9 -- 42.6
14-15 -- 55.1 -- * -- 42.9 -- 44.9
16-17 -- 59.9 -- 12.4 -- 47.3 -- 40.1
GENDER                
Male -- 48.4 -- * -- 33.3 -- 51.6
Female -- 61.6 -- 9.1 -- 52.3 -- 38.4
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 60.7 -- 9.9 -- 50.6 -- 39.3
AIAN -- * -- * -- * -- *
Asian -- * -- * -- * -- *
Black or African American -- * -- * -- * -- *
NHOPI -- * -- * -- * -- *
White -- 64.2 -- 13.7 -- 50.4 -- 35.8
Two or More Races -- * -- * -- * -- *
Hispanic or Latino -- 49.6 -- * -- 35.8 -- 50.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.17A – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Among People Aged 12 to 17 with Past Year Major Depressive Episode
with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought Should
Get Treatment
(2021)
Sought or
Thought Should
Get Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2021)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 760 -- 147 -- 612 -- 560
GEOGRAPHIC REGION                
Northeast -- * -- * -- * -- *
Midwest -- * -- * -- * -- *
South -- 302 -- 49 -- 253 -- 264
West -- * -- * -- 145 -- *
COUNTY TYPE                
Large Metro -- 445 -- 100 -- 344 -- 331
Small Metro -- 224 -- 44 -- 180 -- 173
Nonmetro -- * -- * -- * -- *
POVERTY LEVEL                
Less Than 100% -- * -- * -- * -- *
100-199% -- 186 -- 27 -- 159 -- 179
200% or More -- 442 -- 85 -- 357 -- 261
HEALTH INSURANCE1                
Private -- 400 -- 87 -- 312 -- 248
Medicaid/CHIP -- 333 -- * -- 273 -- 278
Other2 -- * -- * -- * -- *
No Coverage -- * -- * -- * -- *
OVERALL HEALTH3                
Excellent -- * -- * -- * -- *
Very Good -- 312 -- * -- 242 -- 198
Good -- 230 -- 29 -- 201 -- 205
Fair/Poor -- * -- * -- * -- *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
3 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.17B – Sought or Thought Should Get Mental Health Treatment in Past Year: Among People Aged 12 to 17 Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/Health Characteristic Among People Aged 12 to 17 with Past Year Major Depressive Episode
with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year
Sought or
Thought Should
Get Treatment
(2021)
Sought or
Thought Should
Get Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2021)
Thought Should
Get Treatment
but Did Not Seek
Treatment
(2022)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)
Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 57.6 -- 10.8 -- 46.4 -- 42.4
GEOGRAPHIC REGION                
Northeast -- * -- * -- * -- *
Midwest -- * -- * -- * -- *
South -- 53.3 -- 8.4 -- 44.6 -- 46.7
West -- * -- * -- 45.8 -- *
COUNTY TYPE                
Large Metro -- 57.3 -- 12.4 -- 44.4 -- 42.7
Small Metro -- 56.5 -- 11.0 -- 45.4 -- 43.5
Nonmetro -- * -- * -- * -- *
POVERTY LEVEL                
Less Than 100% -- * -- * -- * -- *
100-199% -- 50.9 -- 7.1 -- 43.5 -- 49.1
200% or More -- 62.9 -- 12.0 -- 50.8 -- 37.1
HEALTH INSURANCE1                
Private -- 61.7 -- 13.3 -- 48.2 -- 38.3
Medicaid/CHIP -- 54.5 -- * -- 44.6 -- 45.5
Other2 -- * -- * -- * -- *
No Coverage -- * -- * -- * -- *
OVERALL HEALTH3                
Excellent -- * -- * -- * -- *
Very Good -- 61.1 -- * -- 47.6 -- 38.9
Good -- 52.9 -- 6.2 -- 46.3 -- 47.1
Fair/Poor -- * -- * -- * -- *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
3 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.18A – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year; by Past Year Sought Treatment Status, Numbers in Thousands, 2021 and 2022
Reason Did Not Receive Mental Health Treatment Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Sought or
Thought Should Get Mental Health Treatment in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Thought It Would Cost Too Much -- 626 -- * -- 511
Did Not Have Health Insurance Coverage for Mental Health Treatment -- 169 -- * -- 138
Health Insurance Would Not Pay Enough of Costs for Treatment -- 123 -- * -- 107
Did Not Know How or Where to Get Treatment -- 1,020 -- * -- 817
Could Not Find Treatment Program or Healthcare Professional They
   Wanted to Go to
-- 504 -- * -- 361
No Openings in Treatment Program or with Healthcare Professional
   They Wanted to Go to
-- 154 -- * -- 71
Had Problems with Things Like Transportation, Childcare, or Getting
   Appointments at Times That Worked for Them
-- 393 -- * -- 288
Did Not Have Enough Time for Treatment -- 683 -- * -- 545
Worried That Information Would Not Be Kept Private -- 1,088 -- * -- 921
Worried about What People Would Think or Say if They Got Treatment -- 1,157 -- * -- 994
Thought That if People Knew They Were in Treatment, Bad Things
   Would Happen, Like Losing Their Job, Home, or Children
-- 197 -- * -- 162
Not Ready to Start Treatment -- 892 -- * -- 774
Thought They Should Have Been Able to Handle Their Mental Health,
   Emotions, or Behavior on Their Own
-- 1,740 -- 256 -- 1,483
Thought Their Family, Friends, or Religious Group Would Not Like It if
   They Got Treatment
-- 831 -- * -- 694
Afraid of Being Committed to Hospital or Forced into Treatment against
   Their Will
-- 737 -- * -- 616
Thought They Would Be Told They Needed to Take Medication -- 670 -- * -- 539
Did Not Think Treatment Would Help Them -- 929 -- * -- 794
Thought No One Would Care if They Got Better -- 823 -- * -- 680
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.18B – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year; by Past Year Sought Treatment Status, Percentages, 2021 and 2022
Reason Did Not Receive Mental Health Treatment Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Sought or
Thought Should Get Mental Health Treatment in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Thought It Would Cost Too Much -- 28.9 -- * -- 28.5
Did Not Have Health Insurance Coverage for Mental Health Treatment -- 8.2 -- * -- 8.0
Health Insurance Would Not Pay Enough of Costs for Treatment -- 6.0 -- * -- 6.3
Did Not Know How or Where to Get Treatment -- 46.6 -- * -- 45.1
Could Not Find Treatment Program or Healthcare Professional They
   Wanted to Go to
-- 23.7 -- * -- 20.4
No Openings in Treatment Program or with Healthcare Professional
   They Wanted to Go to
-- 7.1 -- * -- 4.0
Had Problems with Things Like Transportation, Childcare, or Getting
   Appointments at Times That Worked for Them
-- 18.3 -- * -- 16.1
Did Not Have Enough Time for Treatment -- 31.6 -- * -- 30.5
Worried That Information Would Not Be Kept Private -- 49.8 -- * -- 50.9
Worried about What People Would Think or Say if They Got Treatment -- 52.8 -- * -- 54.8
Thought That if People Knew They Were in Treatment, Bad Things
   Would Happen, Like Losing Their Job, Home, or Children
-- 9.0 -- * -- 8.9
Not Ready to Start Treatment -- 41.3 -- * -- 43.3
Thought They Should Have Been Able to Handle Their Mental Health,
   Emotions, or Behavior on Their Own
-- 80.5 -- 69.3 -- 82.8
Thought Their Family, Friends, or Religious Group Would Not Like It if
   They Got Treatment
-- 38.2 -- * -- 38.5
Afraid of Being Committed to Hospital or Forced into Treatment against
   Their Will
-- 34.0 -- * -- 34.3
Thought They Would Be Told They Needed to Take Medication -- 30.7 -- * -- 29.8
Did Not Think Treatment Would Help Them -- 43.0 -- * -- 44.5
Thought No One Would Care if They Got Better -- 38.4 -- * -- 38.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.19A – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year; by Past Year Sought Treatment Status, Numbers in Thousands, 2021 and 2022
Reason Did Not Receive Mental Health Treatment Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental
Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Thought It Would Cost Too Much -- 324 -- * -- 252
Did Not Have Health Insurance Coverage for Mental Health Treatment -- 125 -- * -- 96
Health Insurance Would Not Pay Enough of Costs for Treatment -- 82 -- * -- 66
Did Not Know How or Where to Get Treatment -- 546 -- * -- 419
Could Not Find Treatment Program or Healthcare Professional They
   Wanted to Go to
-- 292 -- * -- 206
No Openings in Treatment Program or with Healthcare Professional
   They Wanted to Go to
-- 114 -- * -- 50
Had Problems with Things Like Transportation, Childcare, or Getting
   Appointments at Times That Worked for Them
-- 235 -- * -- 154
Did Not Have Enough Time for Treatment -- 341 -- * -- 247
Worried That Information Would Not Be Kept Private -- 569 -- * -- 464
Worried about What People Would Think or Say if They Got Treatment -- 590 -- * -- 487
Thought That if People Knew They Were in Treatment, Bad Things
   Would Happen, Like Losing Their Job, Home, or Children
-- 132 -- * -- 102
Not Ready to Start Treatment -- 432 -- * -- 356
Thought They Should Have Been Able to Handle Their Mental Health,
   Emotions, or Behavior on Their Own
-- 844 -- * -- 686
Thought Their Family, Friends, or Religious Group Would Not Like It if
   They Got Treatment
-- 472 -- * -- 387
Afraid of Being Committed to Hospital or Forced into Treatment against
   Their Will
-- 438 -- * -- 342
Thought They Would Be Told They Needed to Take Medication -- 387 -- * -- 295
Did Not Think Treatment Would Help Them -- 501 -- * -- 419
Thought No One Would Care if They Got Better -- 519 -- * -- 421
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.19B – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year; by Past Year Sought Treatment Status, Percentages, 2021 and 2022
Reason Did Not Receive Mental Health Treatment Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental
Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Thought It Would Cost Too Much -- 33.3 -- * -- 31.9
Did Not Have Health Insurance Coverage for Mental Health Treatment -- 13.3 -- * -- 12.5
Health Insurance Would Not Pay Enough of Costs for Treatment -- 8.8 -- * -- 8.7
Did Not Know How or Where to Get Treatment -- 55.5 -- * -- 52.1
Could Not Find Treatment Program or Healthcare Professional They
   Wanted to Go to
-- 30.2 -- * -- 26.2
No Openings in Treatment Program or with Healthcare Professional
   They Wanted to Go to
-- 11.7 -- * -- 6.3
Had Problems with Things Like Transportation, Childcare, or Getting
   Appointments at Times That Worked for Them
-- 24.2 -- * -- 19.4
Did Not Have Enough Time for Treatment -- 34.8 -- * -- 30.9
Worried That Information Would Not Be Kept Private -- 57.8 -- * -- 57.7
Worried about What People Would Think or Say if They Got Treatment -- 59.8 -- * -- 60.4
Thought That if People Knew They Were in Treatment, Bad Things
   Would Happen, Like Losing Their Job, Home, or Children
-- 13.3 -- * -- 12.7
Not Ready to Start Treatment -- 44.5 -- * -- 45.2
Thought They Should Have Been Able to Handle Their Mental Health,
   Emotions, or Behavior on Their Own
-- 86.9 -- * -- 86.6
Thought Their Family, Friends, or Religious Group Would Not Like It if
   They Got Treatment
-- 48.2 -- * -- 48.5
Afraid of Being Committed to Hospital or Forced into Treatment against
   Their Will
-- 45.0 -- * -- 43.2
Thought They Would Be Told They Needed to Take Medication -- 39.4 -- * -- 36.9
Did Not Think Treatment Would Help Them -- 51.5 -- * -- 52.9
Thought No One Would Care if They Got Better -- 53.9 -- * -- 53.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.20A – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year; by Past Year Sought Treatment Status, Numbers in Thousands, 2021 and 2022
Reason Did Not Receive Mental Health Treatment Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did
Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment
in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Thought It Would Cost Too Much -- 266 -- * -- 199
Did Not Have Health Insurance Coverage for Mental Health Treatment -- 100 -- * -- 71
Health Insurance Would Not Pay Enough of Costs for Treatment -- 66 -- * -- 52
Did Not Know How or Where to Get Treatment -- 460 -- * -- 356
Could Not Find Treatment Program or Healthcare Professional They
   Wanted to Go to
-- 237 -- * -- 158
No Openings in Treatment Program or with Healthcare Professional
   They Wanted to Go to
-- 95 -- * -- 35
Had Problems with Things Like Transportation, Childcare, or Getting
   Appointments at Times That Worked for Them
-- 205 -- * -- 132
Did Not Have Enough Time for Treatment -- 267 -- * -- 182
Worried That Information Would Not Be Kept Private -- 453 -- * -- 365
Worried about What People Would Think or Say if They Got Treatment -- 487 -- * -- 406
Thought That if People Knew They Were in Treatment, Bad Things
   Would Happen, Like Losing Their Job, Home, or Children
-- 111 -- * -- 84
Not Ready to Start Treatment -- 344 -- * -- 282
Thought They Should Have Been Able to Handle Their Mental Health,
   Emotions, or Behavior on Their Own
-- 657 -- * -- 529
Thought Their Family, Friends, or Religious Group Would Not Like It if
   They Got Treatment
-- 399 -- * -- 328
Afraid of Being Committed to Hospital or Forced into Treatment against
   Their Will
-- 356 -- * -- 276
Thought They Would Be Told They Needed to Take Medication -- 324 -- * -- 251
Did Not Think Treatment Would Help Them -- 407 -- * -- 339
Thought No One Would Care if They Got Better -- 438 -- * -- 357
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.20B – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year; by Past Year Sought Treatment Status, Percentages, 2021 and 2022
Reason Did Not Receive Mental Health Treatment Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did
Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment
in Past Year
Sought or
Thought
Should Get
Treatment
(2021)
Sought or
Thought
Should Get
Treatment
(2022)
Sought
Treatment
(2021)
Sought
Treatment
(2022)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)
Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)
Thought It Would Cost Too Much -- 35.4 -- * -- 33.0
Did Not Have Health Insurance Coverage for Mental Health Treatment -- 13.9 -- * -- 12.3
Health Insurance Would Not Pay Enough of Costs for Treatment -- 9.2 -- * -- 8.8
Did Not Know How or Where to Get Treatment -- 60.7 -- * -- 58.2
Could Not Find Treatment Program or Healthcare Professional They
   Wanted to Go to
-- 32.0 -- * -- 26.7
No Openings in Treatment Program or with Healthcare Professional
   They Wanted to Go to
-- 12.6 -- * -- 5.7
Had Problems with Things Like Transportation, Childcare, or Getting
   Appointments at Times That Worked for Them
-- 27.3 -- * -- 21.7
Did Not Have Enough Time for Treatment -- 35.2 -- * -- 29.8
Worried That Information Would Not Be Kept Private -- 59.8 -- * -- 59.8
Worried about What People Would Think or Say if They Got Treatment -- 64.1 -- * -- 66.3
Thought That if People Knew They Were in Treatment, Bad Things
   Would Happen, Like Losing Their Job, Home, or Children
-- 14.6 -- * -- 13.8
Not Ready to Start Treatment -- 45.9 -- * -- 47.0
Thought They Should Have Been Able to Handle Their Mental Health,
   Emotions, or Behavior on Their Own
-- 88.3 -- * -- 88.3
Thought Their Family, Friends, or Religious Group Would Not Like It if
   They Got Treatment
-- 52.7 -- * -- 53.8
Afraid of Being Committed to Hospital or Forced into Treatment against
   Their Will
-- 47.2 -- * -- 45.7
Thought They Would Be Told They Needed to Take Medication -- 42.6 -- * -- 41.1
Did Not Think Treatment Would Help Them -- 54.2 -- * -- 56.2
Thought No One Would Care if They Got Better -- 58.8 -- * -- 59.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.21A – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with MDE and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Had MDE
(2021)
Had MDE
(2022)
Had MDE with
Severe
Impairment1
(2021)
Had MDE with
Severe
Impairment1
(2022)
Received
Treatment for
Depression in
Past Year
among People
with MDE2
(2021)
Received
Treatment for
Depression in
Past Year
among People
with MDE2
(2022)
Received
Treatment for
Depression in
Past Year
among People
with MDE
with Severe
Impairment1,2
(2021)
Received
Treatment for
Depression in
Past Year
among People
with MDE
with Severe
Impairment1,2
(2022)
TOTAL 5,186 4,823 3,773 3,595 2,046 2,285 1,631 1,902
AGE GROUP                
12-13 1,130 1,030 788 718 361 474 298 369
14-15 1,754 1,881 1,345 1,419 724 847 597 703
16-17 2,302a 1,911 1,639 1,458 961 964 736 831
GENDER                
Male 1,545 1,452 1,048 996 584 594 420 482
Female 3,641 3,371 2,725 2,599 1,462 1,691 1,210 1,420
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 3,716 3,590 2,740 2,669 1,619 1,750 1,294 1,455
AIAN * 29 * 20 * * * *
Asian 204 230 151 169 * * * *
Black or African American 479 566 367 402 196 192 149 158
NHOPI * * * * * * * *
White 2,703 2,605 1,977 1,970 1,248 1,405 1,020 1,169
Two or More Races 241a 153 167a 101 * * * *
Hispanic or Latino 1,470a 1,233 1,033 926 426 535 336 447
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown impairment data were excluded.
2 Respondents with unknown past year treatment for depression data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.21B – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with MDE and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Had MDE
(2021)
Had MDE
(2022)
Had MDE with
Severe
Impairment1
(2021)
Had MDE with
Severe
Impairment1
(2022)
Received
Treatment for
Depression in
Past Year
among People
with MDE2
(2021)
Received
Treatment for
Depression in
Past Year
among People
with MDE2
(2022)
Received
Treatment for
Depression in
Past Year
among People
with MDE
with Severe
Impairment1,2
(2021)
Received
Treatment for
Depression in
Past Year
among People
with MDE
with Severe
Impairment1,2
(2022)
TOTAL 20.8 19.5 15.2 14.6 40.0b 47.8 43.7b 53.4
AGE GROUP                
12-13 13.5 13.0 9.5 9.1 33.0b 46.9 38.7a 52.2
14-15 21.3 21.4 16.4 16.2 41.5 45.6 44.6 50.2
16-17 27.5a 23.8 19.6 18.2 42.2a 50.5 45.3b 57.0
GENDER                
Male 12.0 11.5 8.2 7.9 38.6 41.3 41.0 49.0
Female 30.1 28.0 22.6 21.7 40.5b 50.6 44.7b 55.1
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 20.0 19.5 14.8 14.5 44.0 49.0 47.6a 54.8
AIAN * 14.1 * 9.7 * * * *
Asian 15.0 14.9 11.1 11.0 * * * *
Black or African American 14.1 16.7 10.8 11.9 41.2 34.5 40.8 40.0
NHOPI * * * * * * * *
White 21.4 21.0 15.7 15.9 46.5a 54.1 51.7a 59.5
Two or More Races 27.9a 19.1 19.2a 12.7 * * * *
Hispanic or Latino 23.1 19.5 16.4 14.7 29.7b 44.3 33.3b 49.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown impairment data were excluded.
2 Respondents with unknown past year treatment for depression data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.22A – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with MDE and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic/
Health Characteristic
Had MDE
(2021)
Had MDE
(2022)
Had MDE
with Severe
Impairment1
(2021)
Had MDE
with Severe
Impairment1
(2022)
Received
Treatment for
Depression in Past
Year among People
with MDE2
(2021)
Received
Treatment for
Depression in Past
Year among People
with MDE2
(2022)
Received
Treatment for
Depression in Past
Year among People
with MDE with
Severe
Impairment1,2
(2021)
Received
Treatment for
Depression in Past
Year among People
with MDE with
Severe
Impairment1,2
(2022)
TOTAL 5,186 4,823 3,773 3,595 2,046 2,285 1,631 1,902
GEOGRAPHIC REGION                
Northeast 811 713 537 510 311 380 228 279
Midwest 1,214b 954 884 735 524 473 405 407
South 1,791 1,888 1,310 1,428 734 832 580 691
West 1,370 1,268 1,041 923 478 600 418 525
COUNTY TYPE                
Large Metro 2,654 2,771 1,938 2,091 1,078 1,302 847a 1,107
Small Metro 1,707 1,524 1,261 1,129 661 756 560 614
Nonmetro 826b 529 573b 375 306 228 224 182
POVERTY LEVEL                
Less Than 100% 963 833 709 616 324 340 283 287
100-199% 1,168 1,149 865 901 439 522 377 437
200% or More 3,055 2,841 2,198 2,079 1,282 1,424 971 1,178
HEALTH INSURANCE3                
Private 2,835 2,700 2,065 1,955 1,230 1,378 941a 1,153
Medicaid/CHIP 2,053 1,989 1,495 1,552 770 915 648 764
Other4 287 295 218 213 * * * *
No Coverage 301b 153 226a 119 * * * *
OVERALL HEALTH5                
Excellent 1,030a 795 653 565 342 312 268 225
Very Good 1,818 1,791 1,318 1,309 776 798 589 687
Good 1,751 1,736 1,309 1,312 645a 867 531a 726
Fair/Poor 588 501 492 409 282 308 243 265
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown impairment data were excluded.
2 Respondents with unknown past year treatment for depression data were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
5 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.22B – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with MDE and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic/
Health Characteristic
Had MDE
(2021)
Had MDE
(2022)
Had MDE
with Severe
Impairment1
(2021)
Had MDE
with Severe
Impairment1
(2022)
Received
Treatment for
Depression in Past
Year among People
with MDE2
(2021)
Received
Treatment for
Depression in Past
Year among People
with MDE2
(2022)
Received
Treatment for
Depression in Past
Year among People
with MDE with
Severe
Impairment1,2
(2021)
Received
Treatment for
Depression in Past
Year among People
with MDE with
Severe
Impairment1,2
(2022)
TOTAL 20.8 19.5 15.2 14.6 40.0b 47.8 43.7b 53.4
GEOGRAPHIC REGION                
Northeast 20.7 18.3 13.7 13.1 39.2a 53.5 43.4 54.9
Midwest 23.0b 18.3 16.8 14.1 43.3 49.7 46.1 55.6
South 18.3 19.4 13.4 14.7 41.4 44.8 44.5 49.3
West 23.0 21.6 17.7 15.7 35.4a 47.6 40.8b 56.9
COUNTY TYPE                
Large Metro 19.8 19.4 14.5 14.7 41.2 47.6 44.3b 53.6
Small Metro 22.0 20.0 16.4 14.8 39.2a 49.8 44.8a 54.6
Nonmetro 21.9 18.8 15.3 13.3 37.6 43.1 39.3 48.4
POVERTY LEVEL                
Less Than 100% 18.4 16.6 13.6 12.3 34.9 41.7 41.4 48.0
100-199% 21.6 20.7 16.1 16.3 38.4 45.6 44.3 48.7
200% or More 21.4 20.1 15.4 14.7 42.1b 50.4 44.2b 57.0
HEALTH INSURANCE3                
Private 21.3 19.8 15.5 14.4 43.6a 51.4 45.7b 59.3
Medicaid/CHIP 19.9 19.5 14.6 15.2 38.5a 46.6 44.4 49.9
Other4 21.7 20.5 16.5 14.8 * * * *
No Coverage 23.7 16.3 18.0 12.7 * * * *
OVERALL HEALTH5                
Excellent 12.6a 10.2 8.0 7.2 33.3 39.2 41.1 39.9
Very Good 19.3 18.3 14.0 13.4 43.4 44.8 45.3 52.6
Good 28.7 29.4 21.4 22.3 37.6b 50.8 41.2b 56.4
Fair/Poor 46.4 41.8 39.5 34.5 48.2a 61.9 49.5a 65.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown impairment data were excluded.
2 Respondents with unknown past year treatment for depression data were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
5 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.23A – Types of Professionals Seen: Among People Aged 12 to 17 with Major Depressive Episode (MDE) and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year; Numbers in Thousands, 2021 and 2022
Type of Professional1 Had MDE
(2021)
Had MDE
(2022)
Had MDE with
Severe Impairment2
(2021)
Had MDE with
Severe Impairment2
(2022)
TOTAL 1,922 2,130 1,553 1,764
HEALTH PROFESSIONAL 1,842 2,052 1,497 1,708
General Practitioner or Family Doctor 521a 731 417b 651
Other Medical Doctor3 115 123 95 115
Psychologist 651 771 519 637
Psychiatrist or Psychotherapist 566 605 474 523
Social Worker 291 372 252 320
Counselor 1,068a 1,334 904a 1,161
Other Mental Health Professional4 313 358 261 314
Nurse, Occupational Therapist, or Other Health Professional 250b 423 226b 387
ALTERNATIVE SERVICE PROFESSIONAL 129 186 107 159
Religious or Spiritual Advisor 72a 137 55a 110
Herbalist, Chiropractor, Acupuncturist, or Massage Therapist 59 56 54 53
OTHER PROFESSIONAL5 2 19 2 17
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row.
2 Respondents with unknown impairment data were excluded.
3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors.
4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified.
5 Respondents with unknown or invalid responses to the write-in question on other types of professionals seen for depression were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.23B – Types of Professionals Seen: Among People Aged 12 to 17 with Major Depressive Episode (MDE) and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year; Percentages, 2021 and 2022
Type of Professional1 Had MDE
(2021)
Had MDE
(2022)
Had MDE with
Severe Impairment2
(2021)
Had MDE with
Severe Impairment2
(2022)
TOTAL 100.0 100.0 100.0 100.0
HEALTH PROFESSIONAL 99.0 98.6 98.8 99.0
General Practitioner or Family Doctor 28.0a 35.1 27.5b 37.7
Other Medical Doctor3 6.2 5.9 6.3 6.7
Psychologist 35.0 37.0 34.3 36.9
Psychiatrist or Psychotherapist 30.4 29.1 31.3 30.3
Social Worker 15.6 17.9 16.7 18.6
Counselor 57.4a 64.1 59.7a 67.3
Other Mental Health Professional4 16.8 17.2 17.3 18.2
Nurse, Occupational Therapist, or Other Health Professional 13.4b 20.3 14.9a 22.4
ALTERNATIVE SERVICE PROFESSIONAL 6.9 8.9 7.1 9.2
Religious or Spiritual Advisor 3.9 6.6 3.6 6.4
Herbalist, Chiropractor, Acupuncturist, or Massage Therapist 3.2 2.7 3.6 3.1
OTHER PROFESSIONAL5 0.1 0.9 0.1 1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row.
2 Respondents with unknown impairment data were excluded.
3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors.
4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified.
5 Respondents with unknown or invalid responses to the write-in question on other types of professionals seen for depression were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.24A – Type of Treatment Received in Past Year for Depression: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; by Demographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic/Socioeconomic Characteristic Saw or Talked
to a Health
Professional
OR Used
Prescription
Medication
(2021)
Saw or Talked
to a Health
Professional
OR Used
Prescription
Medication
(2022)
Saw or Talked
to a Health
Professional
BUT Did Not
Use
Prescription
Medication
(2021)
Saw or Talked
to a Health
Professional
BUT Did Not
Use
Prescription
Medication
(2022)
Used
Prescription
Medication
BUT Did Not
See or Talk
to a Health
Professional
(2021)
Used
Prescription
Medication
BUT Did Not
See or Talk
to a Health
Professional
(2022)
Saw or Talked
to a Health
Professional
AND Used
Prescription
Medication
(2021)
Saw or Talked
to a Health
Professional
AND Used
Prescription
Medication
(2022)
TOTAL 1,989 2,234 930 1,064 120 136 911 980
GENDER                
Male 556 567 230 280 50 39 260 232
Female 1,433 1,667 700 784 71 97 650 748
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 1,580 1,724 715 795 89 121 757 786
AIAN * * * * * * * *
Asian * * * * * * * *
Black or African American 179 186 114 133 * 6 43 45
NHOPI * * * * * * * *
White 1,226 1,387 520 597 62 109 624 663
Two or More Races * * * * 4 * 21 *
Hispanic or Latino 409 510 215 270 32 14 154 194
POVERTY LEVEL                
Less Than 100% 318 333 156 162 29 25 127 126
100-199% 417 506 213 239 33 35 170 227
200% or More 1,254 1,395 561 663 58 76 614 627
HEALTH INSURANCE1                
Private 1,207 1,355 566 641 50 80 573 618
Medicaid/CHIP 752 892 329 438 78 64 333 355
Other2 * * * * * * 49 *
No Coverage * * * * 0 * * *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.24B – Type of Treatment Received in Past Year for Depression: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; by Demographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Demographic/Socioeconomic Characteristic Saw or Talked
to a Health
Professional
OR Used
Prescription
Medication
(2021)
Saw or Talked
to a Health
Professional
OR Used
Prescription
Medication
(2022)
Saw or Talked
to a Health
Professional
BUT Did Not
Use
Prescription
Medication
(2021)
Saw or Talked
to a Health
Professional
BUT Did Not
Use
Prescription
Medication
(2022)
Used
Prescription
Medication
BUT Did Not
See or Talk
to a Health
Professional
(2021)
Used
Prescription
Medication
BUT Did Not
See or Talk
to a Health
Professional
(2022)
Saw or Talked
to a Health
Professional
AND Used
Prescription
Medication
(2021)
Saw or Talked
to a Health
Professional
AND Used
Prescription
Medication
(2022)
TOTAL 39.1b 47.0 18.3a 22.4 2.4 2.9 17.8 20.7
GENDER                
Male 37.4 39.6 15.4 19.5 3.3 2.7 17.3 16.3
Female 39.9b 50.1 19.4 23.6 2.0 2.9 18.0a 22.5
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 43.2 48.5 19.5 22.4 2.4 3.4 20.6 22.1
AIAN * * * * * * * *
Asian * * * * * * * *
Black or African American 38.8 33.6 24.7 24.1 * 1.2 9.2 7.9
NHOPI * * * * * * * *
White 45.8a 53.6 19.4 23.1 2.3 4.2 23.3 25.6
Two or More Races * * * * 1.6 * 8.8 *
Hispanic or Latino 28.7b 42.5 15.1a 22.5 2.2 1.2 10.6a 16.4
POVERTY LEVEL                
Less Than 100% 34.5 40.9 16.8 19.9 3.1 3.1 13.5 15.7
100-199% 36.9 44.5 18.9 21.1 2.9 3.0 14.7 19.9
200% or More 41.4b 49.7 18.5a 23.7 1.9 2.7 20.3 22.4
HEALTH INSURANCE1                
Private 42.9a 50.8 20.1 24.0 1.8 3.0 20.4 23.2
Medicaid/CHIP 37.8a 45.5 16.5a 22.5 3.9 3.3 16.5 18.3
Other2 * * * * * * 17.0 *
No Coverage * * * * 0.1 * * *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.25A – Substance Use in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Numbers in Thousands, 2021 and 2022
Substance Had MDE
(2021)
Had MDE
(2022)
Had MDE with
Severe Impairment1
(2021)
Had MDE with
Severe Impairment1
(2022)
Had No MDE
(2021)
Had No MDE
(2022)
ILLICIT DRUGS2 1,468 1,257 1,187 1,029 2,189 2,289
Marijuana 1,093 1,066 859 895 1,636 1,766
Cocaine 6 25 6 13 18 15
Crack 1 * 1 * 2 *
Heroin * * * * * *
Hallucinogens 147 142 121 122 220 195
LSD 108 84 86 71 155a 72
PCP 5 0 5 0 14 14
Ecstasy 47 29 44 17 44 33
Inhalants 259a 170 228a 138 345 370
Methamphetamine 14 9 14 7 20 8
Misuse of Prescription Psychotherapeutics 415b 249 372b 193 431 371
Pain Relievers 241a 143 219a 111 267 253
Stimulants 145 97 124 75 146 119
Tranquilizers or Sedatives 134 72 131 67 100 61
Tranquilizers 116 57 113 51 90 55
Sedatives 31 21 31 21 11 7
Benzodiazepines 97 56 94 51 91 53
Opioids2 241a 143 219a 111 267 253
Central Nervous System Stimulants 147 123 126 90 169 139
Illicit Drugs Other Than Marijuana2,3 656b 464 570b 362 902 829
TOBACCO PRODUCT USE OR NICOTINE VAPING -- 1,256 -- 991 -- 2,445
Tobacco Products 523a 377 447a 304 917 810
Cigarettes 385 313 323 246 595 540
Daily Cigarettes -- -- -- -- -- --
Smokeless Tobacco 122a 44 97a 43 237a 141
Cigars 198a 106 180a 96 359 296
Pipe Tobacco4 -- -- -- -- -- --
Nicotine Vaping -- 1,206 -- 957 -- 2,228
ALCOHOL 1,754b 1,362 1,359a 1,077 2,846 2,789
Binge Alcohol Use -- -- -- -- -- --
Heavy Alcohol Use -- -- -- -- -- --
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL -- 145 -- 111 -- 265
Illegally Made Fentanyl -- 7 -- 5 -- 14
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown impairment data were excluded.
2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF).
3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.25B – Substance Use in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Percentages, 2021 and 2022
Substance Had MDE
(2021)
Had MDE
(2022)
Had MDE with
Severe Impairment1
(2021)
Had MDE with
Severe Impairment1
(2022)
Had No MDE
(2021)
Had No MDE
(2022)
ILLICIT DRUGS2 28.3 26.1 31.5 28.6 11.1 11.5
Marijuana 21.1 22.1 22.8 24.9 8.3 8.9
Cocaine 0.1 0.5 0.2 0.4 0.1 0.1
Crack 0.0 * 0.0 * 0.0 *
Heroin * * * * * *
Hallucinogens 2.8 3.0 3.2 3.4 1.1 1.0
LSD 2.1 1.8 2.3 2.0 0.8a 0.4
PCP 0.1 0.0 0.1 0.0 0.1 0.1
Ecstasy 0.9 0.6 1.2 0.5 0.2 0.2
Inhalants 5.0 3.5 6.1a 3.8 1.7 1.9
Methamphetamine 0.3 0.2 0.4 0.2 0.1 0.0
Misuse of Prescription Psychotherapeutics 8.0a 5.2 9.9b 5.4 2.2 1.9
Pain Relievers 4.6 3.0 5.8a 3.1 1.3 1.3
Stimulants 2.8 2.0 3.3 2.1 0.7 0.6
Tranquilizers or Sedatives 2.6 1.5 3.5 1.9 0.5 0.3
Tranquilizers 2.2 1.2 3.0 1.4 0.5 0.3
Sedatives 0.6 0.4 0.8 0.6 0.1 0.0
Benzodiazepines 1.9 1.2 2.5 1.4 0.5 0.3
Opioids2 4.6 3.0 5.8a 3.1 1.3 1.3
Central Nervous System Stimulants 2.8 2.6 3.3 2.5 0.9 0.7
Illicit Drugs Other Than Marijuana2,3 12.6a 9.6 15.1b 10.1 4.6 4.2
TOBACCO PRODUCT USE OR NICOTINE VAPING -- 26.0 -- 27.6 -- 12.3
Tobacco Products 10.1 7.8 11.9a 8.4 4.6 4.1
Cigarettes 7.4 6.5 8.6 6.8 3.0 2.7
Daily Cigarettes -- -- -- -- -- --
Smokeless Tobacco 2.4a 0.9 2.6 1.2 1.2a 0.7
Cigars 3.8a 2.2 4.8a 2.7 1.8 1.5
Pipe Tobacco4 -- -- -- -- -- --
Nicotine Vaping -- 25.0 -- 26.6 -- 11.2
ALCOHOL 33.8b 28.2 36.0a 30.0 14.4 14.0
Binge Alcohol Use -- -- -- -- -- --
Heavy Alcohol Use -- -- -- -- -- --
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL -- 3.0 -- 3.1 -- 1.3
Illegally Made Fentanyl -- 0.1 -- 0.1 -- 0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown impairment data were excluded.
2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF).
3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.26A – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder Status and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Substance Use Disorder Status/Age Group Total
(2021)
Total
(2022)
Male
(2021)
Male
(2022)
Female
(2021)
Female
(2022)
SUBSTANCE USE DISORDER1 1,018 922 310 285 708 637
12-13 * * * * * *
14-15 308 315 54 68 254 247
16-17 563 488 * 179 357 309
Drug Use Disorder1 782 769 261 241 522 528
12-13 * * * * * *
14-15 227 273 * * * *
16-17 458 410 * 151 277 259
Alcohol Use Disorder 506a 339 * * 373a 243
12-13 * * * * * *
14-15 * * * * * *
16-17 280 203 * * * 136
NO SUBSTANCE USE DISORDER1 4,168 3,901 1,235 1,167 2,933 2,734
12-13 982 912 198 212 785 700
14-15 1,446 1,566 492 440 954 1,126
16-17 1,739a 1,423 545 516 1,195a 908
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.26B – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder Status and Demographic Characteristics, Percentages, 2021 and 2022
Substance Use Disorder Status/Age Group Total
(2021)
Total
(2022)
Male
(2021)
Male
(2022)
Female
(2021)
Female
(2022)
SUBSTANCE USE DISORDER1 44.5 43.1 31.5 30.1 54.2 53.3
12-13 * * * * * *
14-15 44.7 43.7 20.8 21.6 59.2 60.6
16-17 43.3 43.7 * 36.1 50.9 49.8
Drug Use Disorder1 43.5 44.2 31.8 30.6 53.2 55.6
12-13 * * * * * *
14-15 44.8 44.0 * * * *
16-17 43.0 46.6 * 38.5 49.6 53.1
Alcohol Use Disorder 54.3 46.1 * * 60.6 52.9
12-13 * * * * * *
14-15 * * * * * *
16-17 55.7 45.9 * * * 51.8
NO SUBSTANCE USE DISORDER1 18.4 17.3 10.4 10.0 27.2 25.2
12-13 12.2 12.0 4.7 5.5 20.5 18.6
14-15 19.2 19.4 12.1 10.3 27.5 29.8
16-17 24.6a 20.6 15.2 14.3 34.2a 27.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.27A – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder Status and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Substance Use Disorder Status/Age Group Total
(2021)
Total
(2022)
Male
(2021)
Male
(2022)
Female
(2021)
Female
(2022)
SUBSTANCE USE DISORDER1 781 750 199 199 582 551
12-13 * * * * * *
14-15 269 271 47 54 222 218
16-17 406 400 130 121 276 279
Drug Use Disorder1 617 639 173 180 443 460
12-13 * 59 * * * *
14-15 201 239 39 * * *
16-17 334 341 * 105 220 236
Alcohol Use Disorder 387 279 * 66 292 213
12-13 * * * * * *
14-15 * * * * * *
16-17 200 171 * * * 121
NO SUBSTANCE USE DISORDER1 2,991 2,845 848 797 2,143 2,048
12-13 681 639 117 136 564 503
14-15 1,077 1,148 335 327 741 821
16-17 1,233 1,059 396 335 838 724
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.27B – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder Status and Demographic Characteristics, Percentages, 2021 and 2022
Substance Use Disorder Status/Age Group Total
(2021)
Total
(2022)
Male
(2021)
Male
(2022)
Female
(2021)
Female
(2022)
SUBSTANCE USE DISORDER1 34.3 35.2 20.3 21.1 44.8 46.6
12-13 * * * * * *
14-15 39.1 37.6 18.1 17.1 51.7 53.5
16-17 31.4 35.8 21.7 24.4 39.7 44.8
Drug Use Disorder1 34.3 37.0 21.2 22.8 45.2 49.0
12-13 * 26.0 * * * *
14-15 39.8 38.6 18.1 * * *
16-17 31.3 38.7 * 26.9 39.5 48.3
Alcohol Use Disorder 41.9 38.0 * 23.8 47.9 46.5
12-13 * * * * * *
14-15 * * * * * *
16-17 40.4 38.6 * * * 46.1
NO SUBSTANCE USE DISORDER1 13.2 12.6 7.2 6.8 19.9 18.9
12-13 8.5 8.4 2.8 3.5 14.9 13.4
14-15 14.3 14.2 8.2 7.6 21.4 21.8
16-17 17.5 15.4 11.1 9.3 24.0 22.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.28A – Substance Use Disorder Status in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
MDE Status/
Demographic
Characteristic
SUBSTANCE USE DISORDER STATUS
No Substance
Use
Disorder1
No Substance
Use
Disorder1
Substance Use Disorder
Drugs1 Drugs1 Marijuana Marijuana Opioids1 Opioids1 Alcohol Alcohol Both Drugs
and Alcohol1
Both Drugs
and Alcohol1
Drugs or
Alcohol1
Drugs or
Alcohol1
2021 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021 2022
TOTAL2 23,615 23,498 1,896 1,813 1,348 1,308 275 265 965a 753 458 338 2,404 2,228
MDE 4,168 3,901 782 769 549 542 135 90 506a 339 270 185 1,018 922
Age Group                            
12-13 982 912 98 86 32 35 51 22 60 50 11 17 147 119
14-15 1,446 1,566 227 273 151 186 42 37 166a 85 84 43 308 315
16-17 1,739a 1,423 458 410 365 321 42 31 280 203 175 125 563 488
Gender                            
Male 1,235 1,167 261 241 203 176 43 22 133 96 84 52 310 285
Female 2,933 2,734 522 528 346 366 92 67 373a 243 186 133 708 637
MDE with Severe
Impairment
2,991 2,845 617 639 423 448 119 81 387 279 223 168 781 750
Age Group                            
12-13 681 639 82 59 32 15 36 20 35 36 11 16 106 80
14-15 1,077 1,148 201 239 132 163 42 36 152a 72 84 40 269 271
16-17 1,233 1,059 334 341 260 270 41 25 200 171 128 112 406 400
Gender                            
Male 848 797 173 180 144 129 31 22 96 66 69 46 199 199
Female 2,143 2,048 443 460 279 319 88 59 292 213 153 122 582 551
NO MDE 18,476 18,661 1,017 969 739 721 128 165 426 397 171 147 1,272 1,218
Age Group                            
12-13 7,054 6,688 131 151 48 59 35 58 62 42 38 10 155 183
14-15 6,089 6,497 279 348 191 252 32 60 141 115 40 56 380 407
16-17 5,333 5,477 607 470 500 410 61 47 223 240 93 81 737 629
Gender                            
Male 10,613 10,562 559 547 417 399 45 81 183 180 67 67 675 661
Female 7,863 8,100 459 422 322 322 83 84 243 216 104 81 597 558
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 The Total row includes respondents with unknown past year MDE information.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.28B – Substance Use Disorder Status in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Percentages, 2021 and 2022
MDE Status/
Demographic
Characteristic
SUBSTANCE USE DISORDER STATUS
No Substance
Use
Disorder1
No Substance
Use
Disorder1
Substance Use Disorder
Drugs1 Drugs1 Marijuana Marijuana Opioids1 Opioids1 Alcohol Alcohol Both Drugs
and Alcohol1
Both Drugs
and Alcohol1
Drugs or
Alcohol1
Drugs or
Alcohol1
2021 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021 2022
TOTAL2 90.8 91.3 7.3 7.0 5.2 5.1 1.1 1.0 3.7a 2.9 1.8 1.3 9.2 8.7
MDE 80.4 80.9 15.1 15.9 10.6 11.2 2.6 1.9 9.7a 7.0 5.2 3.8 19.6 19.1
Age Group                            
12-13 87.0 88.5 8.7 8.3 2.9 3.4 4.5 2.2 5.3 4.9 0.9 1.7 13.0 11.5
14-15 82.4 83.2 12.9 14.5 8.6 9.9 2.4 1.9 9.5a 4.5 4.8 2.3 17.6 16.8
16-17 75.6 74.5 19.9 21.5 15.9 16.8 1.8 1.6 12.1 10.6 7.6 6.6 24.4 25.5
Gender                            
Male 79.9 80.4 16.9 16.6 13.1 12.2 2.8 1.5 8.6 6.6 5.4 3.6 20.1 19.6
Female 80.6 81.1 14.3 15.7 9.5 10.9 2.5 2.0 10.2 7.2 5.1 4.0 19.4 18.9
MDE with Severe
Impairment
79.3 79.1 16.3 17.8 11.2 12.5 3.2 2.2 10.3 7.8 5.9 4.7 20.7 20.9
Age Group                            
12-13 86.5 88.9 10.4 8.2 4.0 2.1 4.6 2.7 4.5 5.1 1.4 2.2 13.5 11.1
14-15 80.0 80.9 14.9 16.9 9.8 11.5 3.1 2.5 11.3a 5.1 6.2 2.8 20.0 19.1
16-17 75.2 72.6 20.4 23.4 15.9 18.5 2.5 1.7 12.2 11.7 7.8 7.7 24.8 27.4
Gender                            
Male 81.0 80.0 16.5 18.0 13.7 12.9 2.9 2.2 9.1 6.6 6.6 4.6 19.0 20.0
Female 78.6 78.8 16.3 17.7 10.3 12.3 3.2 2.3 10.7 8.2 5.6 4.7 21.4 21.2
NO MDE 93.6 93.9 5.2 4.9 3.7 3.6 0.6 0.8 2.2 2.0 0.9 0.7 6.4 6.1
Age Group                            
12-13 97.8 97.3 1.8 2.2 0.7 0.9 0.5 0.8 0.9 0.6 0.5 0.1 2.2 2.7
14-15 94.1 94.1 4.3 5.0 3.0 3.6 0.5 0.9 2.2 1.7 0.6 0.8 5.9 5.9
16-17 87.9 89.7 10.0 7.7 8.2 6.7 1.0 0.8 3.7 3.9 1.5 1.3 12.1 10.3
Gender                            
Male 94.0 94.1 4.9 4.9 3.7 3.6 0.4 0.7 1.6 1.6 0.6 0.6 6.0 5.9
Female 92.9 93.6 5.4 4.9 3.8 3.7 1.0 1.0 2.9 2.5 1.2 0.9 7.1 6.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 The Total row includes respondents with unknown past year MDE information.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.29A – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Gender, Numbers in Thousands, 2021 and 2022
Substance Use Disorder and MDE Total
(2021)
Total
(2022)
Male
(2021)
Male
(2022)
Female
(2021)
Female
(2022)
Substance Use Disorder and MDE1 1,018 922 310 285 708 637
Substance Use Disorder and MDE with Severe Impairment1 781 750 199 199 582 551
Drug Use Disorder and MDE1 782 769 261 241 522 528
Drug Use Disorder and MDE with Severe Impairment1 617 639 173 180 443 460
Alcohol Use Disorder and MDE 506a 339 133 96 373a 243
Alcohol Use Disorder and MDE with Severe Impairment 387 279 96 66 292 213
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.29B – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Gender, Percentages, 2021 and 2022
Substance Use Disorder and MDE Total
(2021)
Total
(2022)
Male
(2021)
Male
(2022)
Female
(2021)
Female
(2022)
Substance Use Disorder and MDE1 4.1 3.7 2.4 2.2 5.9 5.3
Substance Use Disorder and MDE with Severe Impairment1 3.1 3.0 1.6 1.6 4.8 4.6
Drug Use Disorder and MDE1 3.1 3.1 2.0 1.9 4.3 4.4
Drug Use Disorder and MDE with Severe Impairment1 2.5 2.6 1.4 1.4 3.7 3.8
Alcohol Use Disorder and MDE 2.0a 1.4 1.0 0.8 3.1a 2.0
Alcohol Use Disorder and MDE with Severe Impairment 1.6 1.1 0.7 0.5 2.4 1.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.30A – Substance Use Disorder (SUD) Severity Level for Specific Substances in Past Year: Among People Aged 12 to 17; by Major Depressive Episode (MDE) or MDE with Severe Impairment Status, Numbers in Thousands, 2021 and 2022
Substance Use Disorder Severity Level Aged 12-17
(2021)
Aged 12-17
(2022)
Had MDE1
(2021)
Had MDE1
(2022)
Had MDE
with Severe
Impairment1,2
(2021)
Had MDE
with Severe
Impairment1,2
(2022)
No MDE1
(2021)
No MDE1
(2022)
TOTAL 26,019 25,726 5,186 4,823 3,773 3,595 19,748 19,880
Substance Use Disorder3 2,404 2,228 1,018 922 781 750 1,272 1,218
Mild SUD 1,326 1,195 517 424 384 326 748 741
Moderate SUD 612 547 260 220 198 177 323 310
Severe SUD 466 486 241 278 199 247 202 167
No SUD 23,615 23,498 4,168 3,901 2,991 2,845 18,476 18,661
Drug Use Disorder3 1,896 1,813 782 769 617 639 1,017 969
Mild SUD 994 894 391 325 291 261 557 548
Moderate SUD 508 464 201 180 159 144 277 268
Severe SUD 394 454 191 263 166 235 183 152
No SUD 24,123 23,913 4,404 4,055 3,156 2,956 18,731 18,911
Marijuana Use Disorder 1,348 1,308 549 542 423 448 739 721
Mild SUD 599 569 225 194 164 157 345 362
Moderate SUD 445 374 184 134 142 104 238 226
Severe SUD 304 365 140 214 118 188 155 133
No SUD 24,671a 24,418 4,637 4,281 3,349 3,147 19,010 19,159
Opioid Use Disorder3 275 265 135 90 119 81 128 165
Mild SUD 183 189 78 55 63 46 101 132
Moderate SUD 33 38 18 14 18 14 6 21
Severe SUD 60 39 39 21 38 21 21 12
No SUD 25,744b 25,461 5,051 4,733 3,653 3,515 19,620 19,714
Alcohol Use Disorder 965a 753 506a 339 387 279 426 397
Mild SUD 677a 498 340a 202 259 154 313 284
Moderate SUD 180 184 100 98 81 91 79 82
Severe SUD 108 71 65 39 48 34 34 30
No SUD 25,054 24,972 4,681 4,484 3,385 3,316 19,322 19,483
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
2 Respondents with unknown impairment data were excluded.
3 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.30B – Substance Use Disorder (SUD) Severity Level for Specific Substances in Past Year: Among People Aged 12 to 17; by Major Depressive Episode (MDE) or MDE with Severe Impairment Status, Percentages, 2021 and 2022
Substance Use Disorder Severity Level Aged 12-17
(2021)
Aged 12-17
(2022)
Had MDE1
(2021)
Had MDE1
(2022)
Had MDE
with Severe
Impairment1,2
(2021)
Had MDE
with Severe
Impairment1,2
(2022)
No MDE1
(2021)
No MDE1
(2022)
TOTAL 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Substance Use Disorder3 9.2 8.7 19.6 19.1 20.7 20.9 6.4 6.1
Mild SUD 5.1 4.6 10.0 8.8 10.2 9.1 3.8 3.7
Moderate SUD 2.4 2.1 5.0 4.6 5.3 4.9 1.6 1.6
Severe SUD 1.8 1.9 4.6 5.8 5.3 6.9 1.0 0.8
No SUD 90.8 91.3 80.4 80.9 79.3 79.1 93.6 93.9
Drug Use Disorder3 7.3 7.0 15.1 15.9 16.3 17.8 5.2 4.9
Mild SUD 3.8 3.5 7.5 6.7 7.7 7.2 2.8 2.8
Moderate SUD 2.0 1.8 3.9 3.7 4.2 4.0 1.4 1.4
Severe SUD 1.5 1.8 3.7a 5.5 4.4 6.5 0.9 0.8
No SUD 92.7 93.0 84.9 84.1 83.7 82.2 94.8 95.1
Marijuana Use Disorder 5.2 5.1 10.6 11.2 11.2 12.5 3.7 3.6
Mild SUD 2.3 2.2 4.3 4.0 4.3 4.4 1.7 1.8
Moderate SUD 1.7 1.5 3.5 2.8 3.8 2.9 1.2 1.1
Severe SUD 1.2 1.4 2.7a 4.4 3.1a 5.2 0.8 0.7
No SUD 94.8 94.9 89.4 88.8 88.8 87.5 96.3 96.4
Opioid Use Disorder3 1.1 1.0 2.6 1.9 3.2 2.2 0.6 0.8
Mild SUD 0.7 0.7 1.5 1.1 1.7 1.3 0.5 0.7
Moderate SUD 0.1 0.1 0.3 0.3 0.5 0.4 0.0 0.1
Severe SUD 0.2 0.2 0.8 0.4 1.0 0.6 0.1 0.1
No SUD 98.9 99.0 97.4 98.1 96.8 97.8 99.4 99.2
Alcohol Use Disorder 3.7a 2.9 9.7a 7.0 10.3 7.8 2.2 2.0
Mild SUD 2.6a 1.9 6.6a 4.2 6.9 4.3 1.6 1.4
Moderate SUD 0.7 0.7 1.9 2.0 2.1 2.5 0.4 0.4
Severe SUD 0.4 0.3 1.3 0.8 1.3 0.9 0.2 0.2
No SUD 96.3a 97.1 90.3a 93.0 89.7 92.2 97.8 98.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
2 Respondents with unknown impairment data were excluded.
3 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.31A – Received Substance Use Treatment and/or Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Age Group, Numbers in Thousands, 2021 and 2022
Substance Use Disorder
Status/MDE Status/Age
Group
Received
Substance Use
Treatment
(SU Tx) OR
Mental Health
(MH) Treatment
(2021)
Received
Substance Use
Treatment
(SU Tx) OR
Mental Health
(MH) Treatment
(2022)
Received
SU Tx
BUT NOT MH
Treatment
(2021)
Received
SU Tx
BUT NOT MH
Treatment
(2022)
Received
MH Treatment
BUT NOT
SU Tx
(2021)
Received
MH Treatment
BUT NOT
SU Tx
(2022)
Received
SU Tx AND
MH Treatment
(2021)
Received
SU Tx AND
MH Treatment
(2022)
Received
NEITHER SU Tx
NOR MH
Treatment
(2021)
Received
NEITHER SU Tx
NOR MH
Treatment
(2022)
Substance Use Disorder
   and MDE
-- 660 -- 14 -- 454 -- 192 -- 262
12-13 -- * -- * -- * -- * -- *
14-15 -- 237 -- 3 -- 154 -- 80 -- 78
16-17 -- 353 -- * -- 244 -- 97 -- 135
Substance Use Disorder
   and MDE with Severe
   Impairment1
-- 557 -- 14 -- 380 -- 163 -- 194
12-13 -- * -- * -- * -- * -- *
14-15 -- * -- 3 -- * -- * -- *
16-17 -- 299 -- * -- 212 -- 76 -- 101
Substance Use Disorder
   and No MDE
-- 465 -- 79 -- 233 -- 154 -- 753
12-13 -- * -- * -- * -- * -- *
14-15 -- 160 -- * -- * -- 37 -- 247
16-17 -- 203 -- 15 -- 126 -- 63 -- 426
MDE and No Substance
   Use Disorder
-- 2,144 -- 49 -- 1,883 -- 211 -- 1,758
12-13 -- 538 -- 16 -- 479 -- 44 -- 373
14-15 -- 871 -- 21 -- 750 -- 100 -- 695
16-17 -- 734 -- 12 -- 654 -- 68 -- 689
No Substance Use Disorder
   and No MDE
-- 4,397 -- 181 -- 3,969 -- 246 -- 14,265
12-13 -- 1,720 -- 46 -- 1,588 -- 87 -- 4,968
14-15 -- 1,544 -- 83 -- 1,365 -- 95 -- 4,953
16-17 -- 1,133 -- 52 -- 1,016 -- 64 -- 4,345
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.31B – Received Substance Use Treatment and/or Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Age Group, Percentages, 2021 and 2022
Substance Use Disorder
Status/MDE Status/Age
Group
Received
Substance Use
Treatment
(SU Tx) OR
Mental Health
(MH) Treatment
(2021)
Received
Substance Use
Treatment
(SU Tx) OR
Mental Health
(MH) Treatment
(2022)
Received
SU Tx
BUT NOT MH
Treatment
(2021)
Received
SU Tx
BUT NOT MH
Treatment
(2022)
Received
MH Treatment
BUT NOT
SU Tx
(2021)
Received
MH Treatment
BUT NOT
SU Tx
(2022)
Received
SU Tx AND
MH Treatment
(2021)
Received
SU Tx AND
MH Treatment
(2022)
Received
NEITHER SU Tx
NOR MH
Treatment
(2021)
Received
NEITHER SU Tx
NOR MH
Treatment
(2022)
Substance Use Disorder
   and MDE
-- 71.6 -- 1.5 -- 49.3 -- 20.8 -- 28.4
12-13 -- * -- * -- * -- * -- *
14-15 -- 75.1 -- 0.9 -- 48.9 -- 25.3 -- 24.9
16-17 -- 72.3 -- * -- 50.1 -- 19.9 -- 27.7
Substance Use Disorder
   and MDE with Severe
   Impairment1
-- 74.2 -- 1.8 -- 50.6 -- 21.7 -- 25.8
12-13 -- * -- * -- * -- * -- *
14-15 -- * -- 1.1 -- * -- * -- *
16-17 -- 74.8 -- * -- 53.1 -- 19.1 -- 25.2
Substance Use Disorder
   and No MDE
-- 38.2 -- 6.5 -- 19.1 -- 12.6 -- 61.8
12-13 -- * -- * -- * -- * -- *
14-15 -- 39.2 -- * -- * -- 9.1 -- 60.8
16-17 -- 32.3 -- 2.3 -- 20.0 -- 10.0 -- 67.7
MDE and No Substance
   Use Disorder
-- 54.9 -- 1.3 -- 48.3 -- 5.4 -- 45.1
12-13 -- 59.1 -- 1.7 -- 52.6 -- 4.8 -- 40.9
14-15 -- 55.6 -- 1.4 -- 47.9 -- 6.4 -- 44.4
16-17 -- 51.6 -- 0.8 -- 46.0 -- 4.8 -- 48.4
No Substance Use Disorder
   and No MDE
-- 23.6 -- 1.0 -- 21.3 -- 1.3 -- 76.4
12-13 -- 25.7 -- 0.7 -- 23.7 -- 1.3 -- 74.3
14-15 -- 23.8 -- 1.3 -- 21.0 -- 1.5 -- 76.2
16-17 -- 20.7 -- 1.0 -- 18.6 -- 1.2 -- 79.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.32A – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic HAD SERIOUS THOUGHTS OF SUICIDE
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
TOTAL 3,355 3,427 18,004 18,347 2,149 1,911 2,419b 1,909
AGE GROUP                
12-13 894 790 6,213 6,243 701 631 1,009b 722
14-15 1,149a 1,389 5,906 6,303 731 661 725 671
16-17 1,312 1,248 5,884 5,801 718 619 685a 517
GENDER                
Male 1,112 1,151 10,438 10,540 891a 701 783 673
Female 2,244 2,277 7,565 7,807 1,258 1,210 1,636b 1,236
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 2,512 2,596 13,529 13,578 1,558 1,451 1,686b 1,351
AIAN * 18 * 158 * 17 * 26
Asian 164 197 986 1,138 166 156 127 108
Black or African American 410 425 2,588 2,510 181 217 326 324
NHOPI * * * * * * * *
White 1,702 1,820 9,232 9,166 1,126 985 1,052a 811
Two or More Races 156 127 559 560 66 71 109 76
Hispanic or Latino 843 832 4,475a 4,769 592 461 733a 558
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.32B – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic HAD SERIOUS THOUGHTS OF SUICIDE
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
TOTAL 12.9 13.4 69.4a 71.7 8.3 7.5 9.3b 7.5
AGE GROUP                
12-13 10.1 9.4 70.5a 74.4 7.9 7.5 11.4b 8.6
14-15 13.5 15.4 69.4 69.9 8.6 7.3 8.5 7.4
16-17 15.3 15.3 68.4 70.9 8.3 7.6 8.0 6.3
GENDER                
Male 8.4 8.8 78.9 80.7 6.7 5.4 5.9 5.1
Female 17.7 18.2 59.6a 62.3 9.9 9.7 12.9b 9.9
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 13.0 13.7 70.2 71.6 8.1 7.6 8.7b 7.1
AIAN * 8.2 * 72.3 * 7.8 * 11.7
Asian 11.4 12.3 68.3 71.2 11.5 9.7 8.8 6.8
Black or African American 11.7 12.2 73.8 72.2 5.2 6.3 9.3 9.3
NHOPI * * * * * * * *
White 13.0 14.2 70.4 71.7 8.6 7.7 8.0a 6.3
Two or More Races 17.5 15.2 62.7 67.1 7.4 8.5 12.3 9.2
Hispanic or Latino 12.7 12.6 67.4a 72.0 8.9 7.0 11.0a 8.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.33A – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic MADE ANY SUICIDE PLANS
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
TOTAL 1,604 1,666 21,294 21,372 1,019 864 2,009a 1,692
AGE GROUP                
12-13 472 436 7,245 7,113 303 248 797a 590
14-15 558 664 6,948 7,396 382 337 622 627
16-17 575 567 7,101 6,864 334 279 589 476
GENDER                
Male 470 461 11,710 11,694 369 340 675 571
Female 1,134 1,206 9,585 9,678 650 524 1,334 1,121
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 1,119 1,291 16,030 15,873 733 586 1,404 1,226
AIAN * * * 172 * 10 14 25
Asian 71 80 1,243 1,342 64 55 65 123
Black or African American 191 262 2,910 2,824 133 114 270 276
NHOPI * * * * * * * *
White 764 874 10,952 10,816 461 365 935a 729
Two or More Races 39 57 715 668 66 40 71 69
Hispanic or Latino 486 375 5,265a 5,500 286 278 605 466
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.33B – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic MADE ANY SUICIDE PLANS
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
TOTAL 6.2 6.5 82.1 83.5 3.9 3.4 7.7a 6.6
AGE GROUP                
12-13 5.3 5.2 82.2 84.8 3.4 3.0 9.0a 7.0
14-15 6.6 7.4 81.6 82.0 4.5 3.7 7.3 6.9
16-17 6.7 6.9 82.6 83.9 3.9 3.4 6.9 5.8
GENDER                
Male 3.6 3.5 88.6 89.5 2.8 2.6 5.1 4.4
Female 8.9 9.6 75.5 77.2 5.1 4.2 10.5 8.9
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 5.8 6.8 83.1 83.6 3.8 3.1 7.3 6.5
AIAN * * * 78.9 * 4.5 8.6 11.5
Asian 4.9 5.0 86.2 83.9 4.4 3.4 4.5 7.7
Black or African American 5.4 7.5 83.0 81.2 3.8 3.3 7.7 7.9
NHOPI * * * * * * * *
White 5.8 6.8 83.5 84.6 3.5 2.9 7.1a 5.7
Two or More Races 4.4 6.8 80.2 80.2 7.5 4.8 7.9 8.3
Hispanic or Latino 7.3 5.7 79.3a 83.1 4.3 4.2 9.1 7.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.34A – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic ATTEMPTED SUICIDE
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
TOTAL 940 953 22,802 22,589 529 553 1,656 1,500
AGE GROUP                
12-13 315 256 7,614 7,378 223 197 665 556
14-15 326 397 7,491 7,900 166 206 528 520
16-17 299 300 7,698 7,311 140 150 463 424
GENDER                
Male 316 295 12,165 12,087 152 205 590 479
Female 623 658 10,638 10,502 377 349 1,066 1,021
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 646 703 17,199b 16,767 342 413 1,097 1,093
AIAN * 5 * 173 1 * * 37
Asian 44 41 1,285 1,397 31 53 84 108
Black or African American 141 164 3,060 2,974 88 96 215 242
NHOPI * * * * * * * *
White 403 437 11,851 11,468 197 236 661 643
Two or More Races 26 48 772 704 25 23 68 58
Hispanic or Latino 294 250 5,603a 5,822 187 140 559a 408
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.34B – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic ATTEMPTED SUICIDE
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
TOTAL 3.6 3.7 87.9 88.3 2.0 2.2 6.4 5.9
AGE GROUP                
12-13 3.6 3.0 86.4 88.0 2.5 2.4 7.5 6.6
14-15 3.8 4.4 88.0 87.5 1.9 2.3 6.2 5.8
16-17 3.5 3.7 89.5 89.3 1.6 1.8 5.4 5.2
GENDER                
Male 2.4 2.3 92.0 92.5 1.2 1.6 4.5 3.7
Female 4.9 5.3 83.7 83.8 3.0 2.8 8.4 8.2
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 3.4 3.7 89.2 88.4 1.8 2.2 5.7 5.8
AIAN * 2.3 * 79.2 0.4 * * 16.8
Asian 3.0 2.6 89.0 87.3 2.2 3.3 5.8 6.8
Black or African American 4.0 4.7 87.3 85.5 2.5 2.8 6.1 7.0
NHOPI * * * * * * * *
White 3.1 3.4 90.4 89.7 1.5 1.9 5.0 5.0
Two or More Races 2.9 5.8 86.7 84.5 2.8 2.7 7.7 7.0
Hispanic or Latino 4.4 3.8 84.4a 88.0 2.8 2.1 8.4a 6.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.35A – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic HAD SERIOUS THOUGHTS OF SUICIDE, MADE ANY
SUICIDE PLANS, OR ATTEMPTED SUICIDE
Any of These
Suicidality Measures
None of These
Suicidality Measures
Unknown
2021 2022 2021 2022 2021 2022
TOTAL 3,506 3,596 17,759 18,160 4,662b 3,839
AGE GROUP            
12-13 944 844 6,118 6,167 1,755b 1,375
14-15 1,209a 1,448 5,826 6,252 1,475 1,323
16-17 1,352 1,304 5,815 5,741 1,432a 1,141
GENDER            
Male 1,177 1,188 10,326 10,431 1,720a 1,446
Female 2,329 2,408 7,433 7,729 2,942b 2,394
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 2,613 2,722 13,336 13,446 3,336b 2,808
AIAN * 21 * 152 * 46
Asian 168 199 979 1,117 296 284
Black or African American 432 471 2,517 2,480 556 526
NHOPI * * * * * *
White 1,774 1,887 9,126 9,106 2,212b 1,791
Two or More Races 158 136 550 545 182 152
Hispanic or Latino 893 874 4,423a 4,713 1,326b 1,032
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: The “Any of These Suicidality Measures” category includes respondents with one or more “yes” responses to suicidal thoughts, plans, or attempts, regardless of whether they had one or more unknown responses for these measures. The “None of These Suicidality Measures” category includes respondents with “no” responses to all three measures. The “Unknown” category includes respondents who did not respond “yes” to any of the three suicidality questions and who responded “not sure/don’t know” or “don’t want to answer/refuse” to any of the three suicidality questions. Respondents with unknown suicide data other than these categories were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.35B – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic HAD SERIOUS THOUGHTS OF SUICIDE, MADE ANY
SUICIDE PLANS, OR ATTEMPTED SUICIDE
Any of These
Suicidality Measures
None of These
Suicidality Measures
Unknown
2021 2022 2021 2022 2021 2022
TOTAL 13.5 14.1 68.5b 70.9 18.0b 15.0
AGE GROUP            
12-13 10.7 10.1 69.4a 73.5 19.9a 16.4
14-15 14.2 16.0 68.5 69.3 17.3a 14.7
16-17 15.7 15.9 67.6 70.1 16.7a 13.9
GENDER            
Male 8.9 9.1 78.1 79.8 13.0a 11.1
Female 18.3 19.2 58.5a 61.7 23.2b 19.1
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 13.5 14.3 69.2 70.9 17.3b 14.8
AIAN * 9.7 * 69.4 * 20.9
Asian 11.6 12.4 67.8 69.8 20.5 17.7
Black or African American 12.3 13.5 71.8 71.3 15.9 15.1
NHOPI * * * * * *
White 13.5 14.8 69.6 71.2 16.9b 14.0
Two or More Races 17.8 16.4 61.8 65.4 20.4 18.3
Hispanic or Latino 13.4 13.2 66.6a 71.2 20.0b 15.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: The “Any of These Suicidality Measures” category includes respondents with one or more “yes” responses to suicidal thoughts, plans, or attempts, regardless of whether they had one or more unknown responses for these measures. The “None of These Suicidality Measures” category includes respondents with “no” responses to all three measures. The “Unknown” category includes respondents who did not respond “yes” to any of the three suicidality questions and who responded “not sure/don’t know” or “don’t want to answer/refuse” to any of the three suicidality questions. Respondents with unknown suicide data other than these categories were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.36A – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Past Year Status of Major Depressive Episode, Receipt of Mental Health Treatment, Sought or Thought Should Get Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Numbers in Thousands, 2021 and 2022
Past Year Mental Health or Substance Use Measure HAD SERIOUS THOUGHTS OF SUICIDE
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
MAJOR DEPRESSIVE EPISODE STATUS                
Major Depressive Episode 2,288 2,241 1,318 1,235 669 693 910b 654
No Major Depressive Episode 980 1,138 16,326 16,720 1,235 1,020 1,193a 956
MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT
SHOULD GET TREATMENT STATUS
               
Mental Health Treatment1 -- 2,034 -- 4,084 -- 716 -- 802
No Mental Health Treatment1 -- 1,394 -- 14,263 -- 1,195 -- 1,107
Sought or Thought Should Get Treatment2 -- 733 -- 868 -- 347 -- 256
Did Not Seek Treatment and Did Not Think Should Get Treatment2 -- 640 -- 13,231 -- 815 -- 774
SUBTANCE USE DISORDER STATUS                
Substance Use Disorder3 831 748 1,089 955 196 284 276 206
Alcohol Use Disorder4 395a 266 353 311 94 107 123 63
Drug Use Disorder3 661 635 875 744 142a 228 208 178
No Substance Use Disorder3 2,524 2,680 16,914 17,392 1,953a 1,628 2,143b 1,703
SUBSTANCE USE TREATMENT STATUS                
Substance Use Treatment5,6 -- 390 -- 515 -- 105 -- 163
No Substance Use Treatment5,6 -- 3,038 -- 17,832 -- 1,807 -- 1,746
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.36B – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Past Year Status of Major Depressive Episode, Receipt of Mental Health Treatment, Sought or Thought Should Get Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Percentages, 2021 and 2022
Past Year Mental Health or Substance Use Measure HAD SERIOUS THOUGHTS OF SUICIDE
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
MAJOR DEPRESSIVE EPISODE STATUS                
Major Depressive Episode 44.1 46.5 25.4 25.6 12.9 14.4 17.6a 13.6
No Major Depressive Episode 5.0 5.7 82.7 84.3 6.3a 5.1 6.0a 4.8
MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT
SHOULD GET TREATMENT STATUS
               
Mental Health Treatment1 -- 26.6 -- 53.5 -- 9.4 -- 10.5
No Mental Health Treatment1 -- 7.8 -- 79.4 -- 6.7 -- 6.2
Sought or Thought Should Get Treatment2 -- 33.3 -- 39.4 -- 15.8 -- 11.6
Did Not Seek Treatment and Did Not Think Should Get Treatment2 -- 4.1 -- 85.6 -- 5.3 -- 5.0
SUBTANCE USE DISORDER STATUS                
Substance Use Disorder3 34.7 34.1 45.5 43.6 8.2a 12.9 11.5 9.4
Alcohol Use Disorder4 40.9 35.6 36.6 41.6 9.7 14.4 12.8 8.4
Drug Use Disorder3 35.0 35.6 46.4 41.7 7.5a 12.8 11.0 10.0
No Substance Use Disorder3 10.7 11.5 71.9a 74.3 8.3a 7.0 9.1b 7.3
SUBSTANCE USE TREATMENT STATUS                
Substance Use Treatment5,6 -- 33.2 -- 43.9 -- 8.9 -- 13.9
No Substance Use Treatment5,6 -- 12.4 -- 73.0 -- 7.4 -- 7.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.37A – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Past Year Status of Major Depressive Episode, Receipt of Mental Health Treatment, Sought or Thought Should Get Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Numbers in Thousands, 2021 and 2022
Past Year Mental Health or Substance Use Measure MADE ANY SUICIDE PLANS
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
MAJOR DEPRESSIVE EPISODE STATUS                
Major Depressive Episode 1,191 1,199 2,750 2,577 407 390 839 658
No Major Depressive Episode 375 443 18,022 18,265 448 354 889 771
MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT
SHOULD GET TREATMENT STATUS
               
Mental Health Treatment1 -- 1,087 -- 5,429 -- 395 -- 724
No Mental Health Treatment1 -- 579 -- 15,943 -- 469 -- 968
Sought or Thought Should Get Treatment2 -- 268 -- 1,547 -- 119 -- 269
Did Not Seek Treatment and Did Not Think Should Get Treatment2 -- 294 -- 14,193 -- 333 -- 639
SUBTANCE USE DISORDER STATUS                
Substance Use Disorder3 519 491 1,419 1,345 113 138 342a 218
Alcohol Use Disorder4 268a 162 506 464 45 31 146 90
Drug Use Disorder3 413 431 1,096 1,054 85 118 293 181
No Substance Use Disorder3 1,086 1,175 19,875 20,027 906 726 1,667 1,474
SUBSTANCE USE TREATMENT STATUS                
Substance Use Treatment5,6 -- 231 -- 689 -- 97 -- 156
No Substance Use Treatment5,6 -- 1,436 -- 20,684 -- 767 -- 1,536
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.37B – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Past Year Status of Major Depressive Episode, Receipt of Mental Health Treatment, Sought or Thought Should Get Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Percentages, 2021 and 2022
Past Year Mental Health or Substance Use Measure MADE ANY SUICIDE PLANS
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
MAJOR DEPRESSIVE EPISODE STATUS                
Major Depressive Episode 23.0 24.9 53.0 53.4 7.8 8.1 16.2 13.6
No Major Depressive Episode 1.9 2.2 91.3 92.1 2.3 1.8 4.5 3.9
MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT
SHOULD GET TREATMENT STATUS
               
Mental Health Treatment1 -- 14.2 -- 71.1 -- 5.2 -- 9.5
No Mental Health Treatment1 -- 3.2 -- 88.8 -- 2.6 -- 5.4
Sought or Thought Should Get Treatment2 -- 12.2 -- 70.2 -- 5.4 -- 12.2
Did Not Seek Treatment and Did Not Think Should Get Treatment2 -- 1.9 -- 91.8 -- 2.2 -- 4.1
SUBTANCE USE DISORDER STATUS                
Substance Use Disorder3 21.7 22.4 59.3 61.4 4.7 6.3 14.3 9.9
Alcohol Use Disorder4 27.8 21.7 52.4 62.2 4.7 4.1 15.1 12.0
Drug Use Disorder3 21.9 24.2 58.1 59.1 4.5 6.6 15.5 10.2
No Substance Use Disorder3 4.6 5.0 84.5 85.6 3.9 3.1 7.1 6.3
SUBSTANCE USE TREATMENT STATUS                
Substance Use Treatment5,6 -- 19.7 -- 58.7 -- 8.3 -- 13.3
No Substance Use Treatment5,6 -- 5.9 -- 84.7 -- 3.1 -- 6.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.38A – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Past Year Status of Major Depressive Episode, Receipt of Mental Health Treatment, Sought or Thought Should Get Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Numbers in Thousands, 2021 and 2022
Past Year Mental Health or Substance Use Measure ATTEMPTED SUICIDE
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
MAJOR DEPRESSIVE EPISODE STATUS                
Major Depressive Episode 668 663 3,580 3,325 183 256 756a 580
No Major Depressive Episode 260 279 18,601 18,690 230 201 644 664
MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT
SHOULD GET TREATMENT STATUS
               
Mental Health Treatment1 -- 619 -- 6,100 -- 265 -- 652
No Mental Health Treatment1 -- 334 -- 16,489 -- 288 -- 848
Sought or Thought Should Get Treatment2 -- 120 -- 1,797 -- 84 -- 202
Did Not Seek Treatment and Did Not Think Should Get Treatment2 -- 201 -- 14,463 -- 193 -- 603
SUBTANCE USE DISORDER STATUS                
Substance Use Disorder3 335 397 1,657 1,479 94 88 306 228
Alcohol Use Disorder4 182 124 614 514 49 23 119 86
Drug Use Disorder3 274 354 1,276 1,171 71 73 265 186
No Substance Use Disorder3 605 556 21,145 21,109 434 465 1,350 1,272
SUBSTANCE USE TREATMENT STATUS                
Substance Use Treatment5,6 -- 163 -- 816 -- 51 -- 142
No Substance Use Treatment5,6 -- 790 -- 21,772 -- 502 -- 1,359
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.38B – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Past Year Status of Major Depressive Episode, Receipt of Mental Health Treatment, Sought or Thought Should Get Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Percentages, 2021 and 2022
Past Year Mental Health or Substance Use Measure ATTEMPTED SUICIDE
Yes No Not Sure/Don’t Know Don’t Want to
Answer/Refuse
2021 2022 2021 2022 2021 2022 2021 2022
MAJOR DEPRESSIVE EPISODE STATUS                
Major Depressive Episode 12.9 13.8 69.0 68.9 3.5a 5.3 14.6 12.0
No Major Depressive Episode 1.3 1.4 94.3 94.2 1.2 1.0 3.3 3.3
MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT
SHOULD GET TREATMENT STATUS
               
Mental Health Treatment1 -- 8.1 -- 79.9 -- 3.5 -- 8.5
No Mental Health Treatment1 -- 1.9 -- 91.8 -- 1.6 -- 4.7
Sought or Thought Should Get Treatment2 -- 5.5 -- 81.6 -- 3.8 -- 9.2
Did Not Seek Treatment and Did Not Think Should Get Treatment2 -- 1.3 -- 93.6 -- 1.2 -- 3.9
SUBTANCE USE DISORDER STATUS                
Substance Use Disorder3 14.0 18.1 69.3 67.5 3.9 4.0 12.8 10.4
Alcohol Use Disorder4 18.8 16.7 63.7 68.8 5.1 3.0 12.3 11.5
Drug Use Disorder3 14.5 19.8 67.7 65.6 3.8 4.1 14.0 10.5
No Substance Use Disorder3 2.6 2.4 89.8 90.2 1.8 2.0 5.7 5.4
SUBSTANCE USE TREATMENT STATUS                
Substance Use Treatment5,6 -- 13.9 -- 69.6 -- 4.4 -- 12.1
No Substance Use Treatment5,6 -- 3.2 -- 89.1 -- 2.1 -- 5.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded.
3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.39A – Attempted Suicide in Past Year: Among People Aged 12 to 17; Received Medical Attention for Suicide Attempt in Past Year and Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year: Among People Aged 12 to 17 Who Attempted Suicide in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Suicidal Behavior/Treatment for
Suicide Attempt
Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
Male
(2021)
Male
(2022)
Female
(2021)
Female
(2022)
ATTEMPTED SUICIDE                        
Yes 940 953 315 256 326 397 299 300 316 295 623 658
No 22,802 22,589 7,614 7,378 7,491 7,900 7,698 7,311 12,165 12,087 10,638 10,502
Not Sure/Don’t Know 529 553 223 197 166 206 140 150 152 205 377 349
Don’t Want to Answer/Refuse 1,656 1,500 665 556 528 520 463 424 590 479 1,066 1,021
RECEIVED MEDICAL ATTENTION
FOR SUICIDE ATTEMPT AMONG
PEOPLE WHO ATTEMPTED
SUICIDE
                       
Yes 305 340 * * * 159 * 101 * * 183 251
No 570 561 * * 198 220 * 183 * * 395 373
Not Sure/Don’t Know 33 30 * 11 6 * * * 7 * 26 17
Don’t Want to Answer/Refuse 31 23 15 8 9 * * * * * 20 17
STAYED OVERNIGHT OR LONGER
IN A HOSPITAL FOR SUICIDE
ATTEMPT AMONG PEOPLE WHO
ATTEMPTED SUICIDE
                       
Yes 170 176 * * * * * 54 * * 101 130
No 695 720 * * * * * 229 * * 476 490
Not Sure/Don’t Know 1 0 1 0 * * * * * 0 1 *
Don’t Want to Answer/Refuse * 4 * * * 3 0 * * * 0 4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230724
Table 7.39B – Attempted Suicide in Past Year: Among People Aged 12 to 17; Received Medical Attention for Suicide Attempt in Past Year and Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year: Among People Aged 12 to 17 Who Attempted Suicide in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Suicidal Behavior/Treatment for
Suicide Attempt
Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
Male
(2021)
Male
(2022)
Female
(2021)
Female
(2022)
ATTEMPTED SUICIDE                        
Yes 3.6 3.7 3.6 3.0 3.8 4.4 3.5 3.7 2.4 2.3 4.9 5.3
No 87.9 88.3 86.4 88.0 88.0 87.5 89.5 89.3 92.0 92.5 83.7 83.8
Not Sure/Don’t Know 2.0 2.2 2.5 2.4 1.9 2.3 1.6 1.8 1.2 1.6 3.0 2.8
Don’t Want to Answer/Refuse 6.4 5.9 7.5 6.6 6.2 5.8 5.4 5.2 4.5 3.7 8.4 8.2
RECEIVED MEDICAL ATTENTION
FOR SUICIDE ATTEMPT AMONG
PEOPLE WHO ATTEMPTED
SUICIDE
                       
Yes 32.5 35.7 * * * 40.2 * 33.6 * * 29.3 38.2
No 60.7 58.8 * * 60.8 55.5 * 61.0 * * 63.4 56.6
Not Sure/Don’t Know 3.5 3.1 * 4.1 1.9 * * * 2.3 * 4.2 2.5
Don’t Want to Answer/Refuse 3.3 2.4 4.7 3.3 2.7 * * * * * 3.2 2.6
STAYED OVERNIGHT OR LONGER
IN A HOSPITAL FOR SUICIDE
ATTEMPT AMONG PEOPLE WHO
ATTEMPTED SUICIDE
                       
Yes 19.4 19.5 * * * * * 19.1 * * 17.4 20.8
No 79.4 80.0 * * * * * 80.4 * * 82.4 78.6
Not Sure/Don’t Know 0.1 0.0 0.3 0.1 * * * * * 0.1 0.1 *
Don’t Want to Answer/Refuse * 0.5 * * * 0.7 0.2 * * * 0.1 0.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

Go to Top of PageGo to the Table of Contents